| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | N,N-dimethylaniline monooxygenase activity | 5.31e-08 | 6 | 156 | 4 | GO:0004499 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | RAD51 MYH2 MYH3 MYH13 CCT3 MYO1E CENPE PSMC1 OLA1 CLPX UBA1 DDX46 DNAH17 AFG3L2 MYO1F KIF4B HSPA1L HSPA2 HSPA5 DYNC1H1 | 7.13e-08 | 614 | 156 | 20 | GO:0140657 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 3.72e-07 | 118 | 156 | 9 | GO:0003774 | |
| GeneOntologyMolecularFunction | hypotaurine monooxygenase activity | 4.62e-06 | 5 | 156 | 3 | GO:0047822 | |
| GeneOntologyMolecularFunction | microfilament motor activity | 1.11e-05 | 38 | 156 | 5 | GO:0000146 | |
| GeneOntologyMolecularFunction | actin filament binding | 1.22e-05 | 227 | 156 | 10 | GO:0051015 | |
| GeneOntologyMolecularFunction | ATP-dependent protein folding chaperone | 1.44e-05 | 40 | 156 | 5 | GO:0140662 | |
| GeneOntologyMolecularFunction | histone H3K9 monomethyltransferase activity | 2.55e-05 | 8 | 156 | 3 | GO:0140948 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | RAD51 MYH3 CCT3 MYO1E PSMC1 OLA1 CLPX DDX46 AFG3L2 HSPA1L HSPA2 HSPA5 DYNC1H1 | 4.44e-05 | 441 | 156 | 13 | GO:0016887 |
| GeneOntologyMolecularFunction | histone H3K9me2 methyltransferase activity | 5.39e-05 | 10 | 156 | 3 | GO:0140947 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | RAD51 PRUNE2 MYH3 RNGTT CCT3 MYO1E GBP7 ENPP1 PSMC1 OLA1 CLPX DDX46 AFG3L2 GNGT2 HSPA1L HSPA2 HSPA5 DYNC1H1 | 1.01e-04 | 839 | 156 | 18 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | RAD51 PRUNE2 MYH3 RNGTT CCT3 MYO1E GBP7 ENPP1 PSMC1 OLA1 CLPX DDX46 AFG3L2 GNGT2 HSPA1L HSPA2 HSPA5 DYNC1H1 | 1.02e-04 | 840 | 156 | 18 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | RAD51 PRUNE2 MYH3 RNGTT CCT3 MYO1E GBP7 ENPP1 PSMC1 OLA1 CLPX DDX46 AFG3L2 GNGT2 HSPA1L HSPA2 HSPA5 DYNC1H1 | 1.02e-04 | 840 | 156 | 18 | GO:0016818 |
| GeneOntologyMolecularFunction | histone H3K9 methyltransferase activity | 1.26e-04 | 13 | 156 | 3 | GO:0046974 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | CACNA1D MYH2 FLNB MYH3 FLNC MYH13 NRCAM MYO1E CENPE CORO1C EPB41L4A SHTN1 EFHC1 MYO1F KIF4B DLEC1 HSPA2 CNGA3 CNN1 MYBPC1 MYBPC2 | 1.33e-04 | 1099 | 156 | 21 | GO:0008092 |
| GeneOntologyMolecularFunction | protein-lysine N-methyltransferase activity | 1.91e-04 | 68 | 156 | 5 | GO:0016279 | |
| GeneOntologyMolecularFunction | lysine N-methyltransferase activity | 2.05e-04 | 69 | 156 | 5 | GO:0016278 | |
| GeneOntologyMolecularFunction | histone methyltransferase activity | 2.35e-04 | 71 | 156 | 5 | GO:0042054 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen | 2.63e-04 | 40 | 156 | 4 | GO:0016709 | |
| GeneOntologyMolecularFunction | protein folding chaperone | 2.67e-04 | 73 | 156 | 5 | GO:0044183 | |
| GeneOntologyMolecularFunction | histone H3 methyltransferase activity | 3.82e-04 | 44 | 156 | 4 | GO:0140938 | |
| GeneOntologyMolecularFunction | actin binding | MYH2 FLNB MYH3 FLNC MYH13 MYO1E CORO1C SHTN1 MYO1F CNN1 MYBPC1 MYBPC2 | 3.93e-04 | 479 | 156 | 12 | GO:0003779 |
| GeneOntologyMolecularFunction | unfolded protein binding | 4.70e-04 | 126 | 156 | 6 | GO:0051082 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in cardiac muscle cell action potential | 5.97e-04 | 5 | 156 | 2 | GO:0086007 | |
| GeneOntologyMolecularFunction | zinc ion binding | POLR3K TRAF3 ENPP1 NPEPPS DYTN NSD1 QTRT2 TRIM39 CLPX MMP20 PHEX SETDB1 AFG3L2 ERVK-19 KDM4A SF3A2 TARS1 | 6.14e-04 | 891 | 156 | 17 | GO:0008270 |
| GeneOntologyMolecularFunction | ankyrin binding | 7.39e-04 | 23 | 156 | 3 | GO:0030506 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | RAD51 MYH3 CCT3 MYO1E GBP7 PSMC1 OLA1 CLPX DDX46 AFG3L2 GNGT2 HSPA1L HSPA2 HSPA5 DYNC1H1 | 1.12e-03 | 775 | 156 | 15 | GO:0017111 |
| GeneOntologyMolecularFunction | glutamate receptor activity | 1.19e-03 | 27 | 156 | 3 | GO:0008066 | |
| GeneOntologyMolecularFunction | protein methyltransferase activity | 1.29e-03 | 103 | 156 | 5 | GO:0008276 | |
| GeneOntologyMolecularFunction | N-methyltransferase activity | 1.41e-03 | 105 | 156 | 5 | GO:0008170 | |
| GeneOntologyMolecularFunction | ATP-dependent peptidase activity | 1.65e-03 | 8 | 156 | 2 | GO:0004176 | |
| GeneOntologyMolecularFunction | structural constituent of presynaptic active zone | 1.65e-03 | 8 | 156 | 2 | GO:0098882 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of cytosolic calcium levels | 2.11e-03 | 9 | 156 | 2 | GO:0099511 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels | 2.11e-03 | 9 | 156 | 2 | GO:0099626 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 2.20e-03 | 70 | 156 | 4 | GO:0003777 | |
| GeneOntologyMolecularFunction | calmodulin binding | 2.24e-03 | 230 | 156 | 7 | GO:0005516 | |
| GeneOntologyMolecularFunction | intracellularly cAMP-activated cation channel activity | 2.62e-03 | 10 | 156 | 2 | GO:0005222 | |
| GeneOntologyMolecularFunction | histone H4K20 methyltransferase activity | 2.62e-03 | 10 | 156 | 2 | GO:0042799 | |
| GeneOntologyCellularComponent | myosin filament | 1.23e-06 | 25 | 162 | 5 | GO:0032982 | |
| GeneOntologyCellularComponent | myosin complex | 9.38e-05 | 59 | 162 | 5 | GO:0016459 | |
| GeneOntologyCellularComponent | cell cortex | MYH2 FLNB MYO1E CORO1C PCLO IQSEC2 EXOC8 MYO1F TLE6 RIMBP2 DYNC1H1 | 1.56e-04 | 371 | 162 | 11 | GO:0005938 |
| GeneOntologyCellularComponent | muscle myosin complex | 2.38e-04 | 16 | 162 | 3 | GO:0005859 | |
| GeneOntologyCellularComponent | myofibril | 2.88e-04 | 273 | 162 | 9 | GO:0030016 | |
| GeneOntologyCellularComponent | supramolecular fiber | CACNA1D MYH2 FLNB MYH3 FLNC RPGRIP1L MYH13 CCT3 CENPE CORO1C HAUS3 SHTN1 EFHC1 DNAH17 MYO1F ASPM KIF4B CTPS1 DYNC1H1 MYBPC1 MYBPC2 | 3.17e-04 | 1179 | 162 | 21 | GO:0099512 |
| GeneOntologyCellularComponent | cell body | CFH CACNA1D FLNB CCT3 ENPP1 PCLO GRIA4 GRIK1 HCN2 SHTN1 CIT EFHC1 SYT5 KDR HSPA1L HSPA5 CNGA3 DYNC1H1 | 3.24e-04 | 929 | 162 | 18 | GO:0044297 |
| GeneOntologyCellularComponent | supramolecular polymer | CACNA1D MYH2 FLNB MYH3 FLNC RPGRIP1L MYH13 CCT3 CENPE CORO1C HAUS3 SHTN1 EFHC1 DNAH17 MYO1F ASPM KIF4B CTPS1 DYNC1H1 MYBPC1 MYBPC2 | 3.47e-04 | 1187 | 162 | 21 | GO:0099081 |
| GeneOntologyCellularComponent | contractile muscle fiber | 4.47e-04 | 290 | 162 | 9 | GO:0043292 | |
| GeneOntologyCellularComponent | glutamatergic synapse | DOCK1 PRUNE2 CACNA2D1 NRCAM PCLO IQSEC2 SYT6 SH3GLB2 GRIA4 GRID2 GRIK1 RNF10 IQSEC1 SYN2 RIMBP2 EPHB1 | 6.28e-04 | 817 | 162 | 16 | GO:0098978 |
| GeneOntologyCellularComponent | presynaptic active zone cytoplasmic component | 7.22e-04 | 23 | 162 | 3 | GO:0098831 | |
| GeneOntologyCellularComponent | sarcomere | 7.40e-04 | 249 | 162 | 8 | GO:0030017 | |
| GeneOntologyCellularComponent | neuronal cell body | CFH CACNA1D FLNB ENPP1 PCLO GRIA4 GRIK1 HCN2 SHTN1 CIT EFHC1 SYT5 KDR HSPA5 CNGA3 DYNC1H1 | 7.92e-04 | 835 | 162 | 16 | GO:0043025 |
| GeneOntologyCellularComponent | presynaptic active zone | 8.18e-04 | 141 | 162 | 6 | GO:0048786 | |
| GeneOntologyCellularComponent | kainate selective glutamate receptor complex | 8.77e-04 | 6 | 162 | 2 | GO:0032983 | |
| GeneOntologyCellularComponent | U2 snRNP | 1.30e-03 | 28 | 162 | 3 | GO:0005686 | |
| GeneOntologyCellularComponent | myosin II complex | 1.30e-03 | 28 | 162 | 3 | GO:0016460 | |
| GeneOntologyCellularComponent | postsynaptic density membrane | 1.42e-03 | 157 | 162 | 6 | GO:0098839 | |
| GeneOntologyCellularComponent | myelin sheath | 1.55e-03 | 217 | 162 | 7 | GO:0043209 | |
| GeneOntologyCellularComponent | actin cytoskeleton | MYH2 FLNB MYH3 FLNC MYH13 MYO1E CORO1C RGS22 CIT MYO1F CNN1 TNS3 | 1.82e-03 | 576 | 162 | 12 | GO:0015629 |
| GeneOntologyCellularComponent | ribbon synapse | 1.92e-03 | 32 | 162 | 3 | GO:0097470 | |
| Domain | IQ | 1.05e-07 | 71 | 151 | 8 | PF00612 | |
| Domain | IQ_motif_EF-hand-BS | 6.71e-07 | 90 | 151 | 8 | IPR000048 | |
| Domain | IQ | 8.64e-07 | 93 | 151 | 8 | PS50096 | |
| Domain | TEA_1 | 2.06e-06 | 4 | 151 | 3 | PS00554 | |
| Domain | TEA_2 | 2.06e-06 | 4 | 151 | 3 | PS51088 | |
| Domain | TEA | 2.06e-06 | 4 | 151 | 3 | PF01285 | |
| Domain | TEA/ATTS_dom | 2.06e-06 | 4 | 151 | 3 | IPR000818 | |
| Domain | TEF_metazoa | 2.06e-06 | 4 | 151 | 3 | IPR016361 | |
| Domain | TEA | 2.06e-06 | 4 | 151 | 3 | SM00426 | |
| Domain | Flavin_mOase | 5.12e-06 | 5 | 151 | 3 | IPR000960 | |
| Domain | DiMe-aniline_mOase | 5.12e-06 | 5 | 151 | 3 | IPR012143 | |
| Domain | FMO-like | 5.12e-06 | 5 | 151 | 3 | PF00743 | |
| Domain | Flavin_mOase-like | 5.12e-06 | 5 | 151 | 3 | IPR020946 | |
| Domain | Myosin_head_motor_dom | 1.31e-05 | 38 | 151 | 5 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 1.31e-05 | 38 | 151 | 5 | PS51456 | |
| Domain | Myosin_head | 1.31e-05 | 38 | 151 | 5 | PF00063 | |
| Domain | MYSc | 1.31e-05 | 38 | 151 | 5 | SM00242 | |
| Domain | Myosin-like_IQ_dom | 1.45e-05 | 19 | 151 | 4 | IPR027401 | |
| Domain | - | 1.45e-05 | 19 | 151 | 4 | 4.10.270.10 | |
| Domain | - | 1.08e-04 | 12 | 151 | 3 | 2.60.34.10 | |
| Domain | HSP70_peptide-bd | 1.08e-04 | 12 | 151 | 3 | IPR029047 | |
| Domain | - | 1.40e-04 | 13 | 151 | 3 | 1.20.1270.10 | |
| Domain | Heat_shock_70_CS | 1.40e-04 | 13 | 151 | 3 | IPR018181 | |
| Domain | HSP70_C | 1.40e-04 | 13 | 151 | 3 | IPR029048 | |
| Domain | P-loop_NTPase | RAD51 MYH2 MYH3 MYH13 MYO1E GBP7 CENPE PSMC1 OLA1 CLPX DDX46 HS2ST1 AFG3L2 MYO1F ASPM KIF4B CTPS1 DYNC1H1 | 1.73e-04 | 848 | 151 | 18 | IPR027417 |
| Domain | - | 1.77e-04 | 14 | 151 | 3 | 3.10.20.30 | |
| Domain | Beta-grasp_dom | 1.77e-04 | 14 | 151 | 3 | IPR012675 | |
| Domain | IQSEC_PH | 1.94e-04 | 3 | 151 | 2 | IPR033742 | |
| Domain | IQ_SEC7_PH | 1.94e-04 | 3 | 151 | 2 | PF16453 | |
| Domain | Myosin_N | 2.19e-04 | 15 | 151 | 3 | PF02736 | |
| Domain | Myosin_N | 2.19e-04 | 15 | 151 | 3 | IPR004009 | |
| Domain | Post-SET_dom | 2.69e-04 | 16 | 151 | 3 | IPR003616 | |
| Domain | PostSET | 2.69e-04 | 16 | 151 | 3 | SM00508 | |
| Domain | HSP70 | 2.69e-04 | 16 | 151 | 3 | PF00012 | |
| Domain | POST_SET | 2.69e-04 | 16 | 151 | 3 | PS50868 | |
| Domain | HSP70_2 | 3.24e-04 | 17 | 151 | 3 | PS00329 | |
| Domain | HSP70_1 | 3.24e-04 | 17 | 151 | 3 | PS00297 | |
| Domain | HSP70_3 | 3.24e-04 | 17 | 151 | 3 | PS01036 | |
| Domain | SET | 3.29e-04 | 41 | 151 | 4 | PF00856 | |
| Domain | SH3_1 | 3.79e-04 | 164 | 151 | 7 | PF00018 | |
| Domain | SH3 | 3.79e-04 | 216 | 151 | 8 | SM00326 | |
| Domain | SH3 | 3.79e-04 | 216 | 151 | 8 | PS50002 | |
| Domain | Prot_disulphide_isomerase | 3.85e-04 | 4 | 151 | 2 | IPR005792 | |
| Domain | Lig_chan-Glu_bd | 3.87e-04 | 18 | 151 | 3 | PF10613 | |
| Domain | Myosin_tail_1 | 3.87e-04 | 18 | 151 | 3 | PF01576 | |
| Domain | Myosin_tail | 3.87e-04 | 18 | 151 | 3 | IPR002928 | |
| Domain | Glu/Gly-bd | 3.87e-04 | 18 | 151 | 3 | IPR019594 | |
| Domain | Lig_chan-Glu_bd | 3.87e-04 | 18 | 151 | 3 | SM00918 | |
| Domain | Iontro_rcpt | 3.87e-04 | 18 | 151 | 3 | IPR001320 | |
| Domain | Iono_rcpt_met | 3.87e-04 | 18 | 151 | 3 | IPR001508 | |
| Domain | Lig_chan | 3.87e-04 | 18 | 151 | 3 | PF00060 | |
| Domain | PBPe | 3.87e-04 | 18 | 151 | 3 | SM00079 | |
| Domain | Hsp_70_fam | 3.87e-04 | 18 | 151 | 3 | IPR013126 | |
| Domain | SH3_9 | 4.25e-04 | 78 | 151 | 5 | PF14604 | |
| Domain | SH3_domain | 4.29e-04 | 220 | 151 | 8 | IPR001452 | |
| Domain | IQ | 5.05e-04 | 81 | 151 | 5 | SM00015 | |
| Domain | SET | 5.15e-04 | 46 | 151 | 4 | SM00317 | |
| Domain | Synaptotagmin | 5.34e-04 | 20 | 151 | 3 | IPR001565 | |
| Domain | AWS | 6.39e-04 | 5 | 151 | 2 | SM00570 | |
| Domain | AWS | 6.39e-04 | 5 | 151 | 2 | PS51215 | |
| Domain | AWS_dom | 6.39e-04 | 5 | 151 | 2 | IPR006560 | |
| Domain | SET_dom | 7.08e-04 | 50 | 151 | 4 | IPR001214 | |
| Domain | SET | 7.08e-04 | 50 | 151 | 4 | PS50280 | |
| Domain | Myosin_TH1 | 1.33e-03 | 7 | 151 | 2 | PF06017 | |
| Domain | TGS-like | 1.33e-03 | 7 | 151 | 2 | IPR012676 | |
| Domain | Myosin_TH1 | 1.33e-03 | 7 | 151 | 2 | IPR010926 | |
| Domain | TH1 | 1.33e-03 | 7 | 151 | 2 | PS51757 | |
| Domain | Disulphide_isomerase | 1.76e-03 | 8 | 151 | 2 | IPR005788 | |
| Domain | CH | 1.90e-03 | 65 | 151 | 4 | SM00033 | |
| Domain | CH | 2.49e-03 | 70 | 151 | 4 | PF00307 | |
| Domain | - | 2.62e-03 | 71 | 151 | 4 | 1.10.418.10 | |
| Domain | IG_FLMN | 2.80e-03 | 10 | 151 | 2 | SM00557 | |
| Domain | CH | 2.90e-03 | 73 | 151 | 4 | PS50021 | |
| Domain | CH-domain | 3.20e-03 | 75 | 151 | 4 | IPR001715 | |
| Domain | ANF_lig-bd_rcpt | 3.29e-03 | 37 | 151 | 3 | IPR001828 | |
| Domain | ANF_receptor | 3.29e-03 | 37 | 151 | 3 | PF01094 | |
| Domain | Filamin | 3.40e-03 | 11 | 151 | 2 | PF00630 | |
| Domain | FILAMIN_REPEAT | 3.40e-03 | 11 | 151 | 2 | PS50194 | |
| Domain | Filamin/ABP280_rpt | 3.40e-03 | 11 | 151 | 2 | IPR001298 | |
| Domain | Filamin/ABP280_repeat-like | 3.40e-03 | 11 | 151 | 2 | IPR017868 | |
| Domain | Peripla_BP_I | 3.83e-03 | 39 | 151 | 3 | IPR028082 | |
| Domain | FN3 | 3.97e-03 | 185 | 151 | 6 | SM00060 | |
| Domain | Ig_I-set | 4.52e-03 | 190 | 151 | 6 | IPR013098 | |
| Domain | I-set | 4.52e-03 | 190 | 151 | 6 | PF07679 | |
| Domain | NA-bd_OB-fold | 4.60e-03 | 83 | 151 | 4 | IPR012340 | |
| Domain | Thioredoxin | 4.78e-03 | 13 | 151 | 2 | IPR005746 | |
| Domain | K_chnl_volt-dep_EAG/ELK/ERG | 5.54e-03 | 14 | 151 | 2 | IPR003938 | |
| Domain | AAA | 6.33e-03 | 144 | 151 | 5 | SM00382 | |
| Domain | AAA+_ATPase | 6.33e-03 | 144 | 151 | 5 | IPR003593 | |
| Domain | - | 6.36e-03 | 15 | 151 | 2 | 1.10.1000.11 | |
| Domain | Sec7 | 6.36e-03 | 15 | 151 | 2 | PF01369 | |
| Domain | Sec7_alpha_orthog | 6.36e-03 | 15 | 151 | 2 | IPR023394 | |
| Domain | FN3_dom | 7.12e-03 | 209 | 151 | 6 | IPR003961 | |
| Domain | cNMP-bd_CS | 7.23e-03 | 16 | 151 | 2 | IPR018488 | |
| Domain | SEC7 | 7.23e-03 | 16 | 151 | 2 | PS50190 | |
| Domain | Sec7 | 7.23e-03 | 16 | 151 | 2 | SM00222 | |
| Domain | Sec7_dom | 7.23e-03 | 16 | 151 | 2 | IPR000904 | |
| Pathway | WP_CATALYTIC_CYCLE_OF_MAMMALIAN_FLAVINCONTAINING_MONOOXYGENASES_FMOS | 7.39e-06 | 5 | 129 | 3 | M39449 | |
| Pathway | REACTOME_RUNX3_REGULATES_YAP1_MEDIATED_TRANSCRIPTION | 1.47e-05 | 6 | 129 | 3 | MM15544 | |
| Pathway | REACTOME_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION | 4.05e-05 | 8 | 129 | 3 | MM14816 | |
| Pathway | REACTOME_RUNX3_REGULATES_YAP1_MEDIATED_TRANSCRIPTION | 4.05e-05 | 8 | 129 | 3 | M27823 | |
| Pathway | KEGG_LYSINE_DEGRADATION | 4.84e-05 | 44 | 129 | 5 | M13720 | |
| Pathway | WP_NPHP1_DELETION_SYNDROME | 1.17e-04 | 11 | 129 | 3 | M48099 | |
| Pubmed | HNRNPDL MYH2 FLNB MYH3 FLNC MYH13 CCT3 PCLO ASH1L GRIA4 CLPX PDIA3 NDUFS1 ADCY6 NDUFV2 PDIA4 PHEX EEF1B2 LIG4 CDK13 ASPM KDR BOD1L1 DLEC1 HADHA ZBTB11 KIAA2012 HSPA1L HSPA2 HSPA5 SF3A2 MYBPC1 MYBPC2 | 3.95e-14 | 1442 | 164 | 33 | 35575683 | |
| Pubmed | FLNB CACNA2D1 FLNC NRCAM CCT3 MYO1E NPEPPS CORO1C PCLO IQSEC2 PSMC1 OLA1 CIT PDIA3 NDUFS1 CYRIB YARS1 NDUFV2 EEF1B2 PPP2R2C UBA1 AFG3L2 IQSEC1 SYN2 RIMBP2 HADHA HSPA2 HSPA5 TARS1 DYNC1H1 TP53BP2 | 1.10e-12 | 1431 | 164 | 31 | 37142655 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | HNRNPDL FLNB FLNC MRPS28 CCT3 NPEPPS CORO1C SF3A1 PSMC1 SH3GLB2 QTRT2 OLA1 CLPX PDIA3 CYRIB PDIA4 SETDB1 EEF1B2 UBA1 DDX46 OCIAD1 AGL HADHA ATOX1 CTPS1 EXOSC7 HSPA1L HSPA5 SF3A2 TNS3 | 1.94e-12 | 1367 | 164 | 30 | 32687490 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | HNRNPDL FLNB RBM15 CCT3 NPEPPS CORO1C SF3A1 PCLO RGS22 PSMC1 OLA1 DBT CLPX CBS PDIA3 NDUFS1 TBL3 YARS1 PDIA4 EEF1B2 UBA1 TRMT6 BOD1L1 HADHA CTPS1 HSPA5 TARS1 DYNC1H1 MYBPC1 | 2.92e-11 | 1425 | 164 | 29 | 30948266 |
| Pubmed | FLNB RBM15 CCT3 NPEPPS PSMC1 QTRT2 CBS PDIA3 NDUFS1 CYRIB YARS1 EXOC8 PDIA4 EEF1B2 PPP2R2C UBA1 CSK CDK13 HADHA CTPS1 HSPA5 TARS1 DYNC1H1 | 3.12e-11 | 878 | 164 | 23 | 37223481 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | RAD51 PRUNE2 FLNB FLNC CCT3 MYO1E NPEPPS CORO1C SF3A1 PSMC1 SH3GLB2 OLA1 SHTN1 CBS PDIA3 YARS1 PDIA4 EEF1B2 UBA1 TRMT6 PPP2R5D AGL TIMELESS CTPS1 HSPA1L HSPA5 TARS1 DYNC1H1 TNS3 | 4.78e-11 | 1455 | 164 | 29 | 22863883 |
| Pubmed | SF3A1 PSMC1 DBT CLPX PDIA3 NDUFS1 NDUFV2 UBA1 DDX46 OCIAD1 CLYBL AFG3L2 BOD1L1 HADHA DYNC1H1 | 6.39e-11 | 331 | 164 | 15 | 29199018 | |
| Pubmed | CCT3 PSMC1 OLA1 PDIA3 UBA1 DDX46 CTPS1 HSPA1L HSPA5 TARS1 DYNC1H1 | 8.55e-11 | 142 | 164 | 11 | 30809309 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | HNRNPDL FLNB CACNA2D1 FLNC RBM15 CCT3 NPEPPS CORO1C SF3A1 PSMC1 OLA1 CIT PDIA3 TBL3 PDIA4 EEF1B2 UBA1 DDX46 AFG3L2 HADHA HSPA5 SF3A2 TARS1 DYNC1H1 | 1.09e-10 | 1024 | 164 | 24 | 24711643 |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | HNRNPDL FLNB FLNC MRPS28 CCT3 NPEPPS CORO1C SF3A1 PSMC1 SHTN1 PDIA3 YARS1 PDIA4 EEF1B2 UBA1 DDX46 AGL HADHA CTPS1 CPVL HSPA1L HSPA2 HSPA5 TARS1 DYNC1H1 | 2.01e-10 | 1149 | 164 | 25 | 35446349 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | FLNB FLNC CCT3 NPEPPS CORO1C PCLO ASH1L AP1M2 OLA1 PDIA3 CYRIB PDIA4 EEF1B2 ARID1B FBP1 HADHA HSPA1L HSPA2 HSPA5 TARS1 DYNC1H1 | 2.72e-10 | 807 | 164 | 21 | 30575818 |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | RPGRIP1L RNGTT MRPS28 MYO1E SF3A1 IQSEC2 QTRT2 OLA1 CBS PDIA3 NDUFS1 ADCY6 TMED4 EXOC8 CLASRP SETDB1 UBA1 EFHC1 PPP2R5D OCIAD1 AFG3L2 EXOSC7 HSPA1L HSPA5 DYNC1H1 TP53BP2 | 7.10e-10 | 1321 | 164 | 26 | 27173435 |
| Pubmed | RBM15 RPGRIP1L RNGTT CCT3 CORO1C PSMC1 DBT CLPX PDIA3 PDIA4 ARID1B UBA1 PPP2R5D OCIAD1 CSK PTPRR AFG3L2 HADHA CPVL HSPA2 HSPA5 TNS3 TP53BP2 | 9.94e-10 | 1049 | 164 | 23 | 27880917 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | HNRNPDL FLNB FLNC RBM15 MRPS28 CCT3 NPEPPS CORO1C PSMC1 CLPX PDIA3 NDUFS1 TBL3 EEF1B2 UBA1 AFG3L2 ASPM IQSEC1 HADHA CTPS1 HSPA1L HSPA5 TARS1 DYNC1H1 TNS3 TP53BP2 | 1.17e-09 | 1353 | 164 | 26 | 29467282 |
| Pubmed | HNRNPDL FLNC CCT3 SF3A1 OLA1 DBT CBS PDIA3 YARS1 EEF1B2 UBA1 PPP2R5D BOD1L1 HADHA CTPS1 NFAT5 HSPA5 SF3A2 TARS1 DYNC1H1 | 1.80e-09 | 809 | 164 | 20 | 32129710 | |
| Pubmed | HNRNPDL FLNB FLNC CCT3 NPEPPS SF3A1 PSMC1 TBL3 PDIA4 EEF1B2 UBA1 AGL CTPS1 HSPA1L HSPA5 TARS1 | 1.93e-09 | 494 | 164 | 16 | 26831064 | |
| Pubmed | FLNB CACNA2D1 TRAF3 CCT3 ENPP1 PSMC1 QTRT2 CLPX CBS PDIA3 NDUFS1 TBL3 YARS1 TMED4 PDIA4 EEF1B2 UBA1 PPP2R5D AFG3L2 BOD1L1 HADHA CTPS1 HSPA5 SF3A2 DYNC1H1 | 2.39e-09 | 1297 | 164 | 25 | 33545068 | |
| Pubmed | DOCK1 MYH2 FLNC CCT3 ENPP1 NPEPPS SF3A1 PSMC1 SH3GLB2 AGL AFG3L2 HADHA CPVL TARS1 TP53BP2 | 2.91e-09 | 437 | 164 | 15 | 20562859 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | HNRNPDL FLNB MRPS28 CCT3 MYO1E SF3A1 PSMC1 OLA1 CLPX CBS PDIA3 YARS1 EEF1B2 UBA1 DDX46 PPP2R5D CDK13 AGL AFG3L2 PPIE HADHA CTPS1 EXOSC7 HSPA5 TARS1 DYNC1H1 | 2.98e-09 | 1415 | 164 | 26 | 28515276 |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | HNRNPDL CACNA2D1 CCT3 CENPE CORO1C SF3A1 HAUS3 CLPX PDIA3 TMED4 PDIA4 ARID1B UBA1 DDX46 PPP2R5D CSK ASPM KIF4B PPIE TIMELESS HADHA SF3A2 DYNC1H1 | 6.10e-09 | 1155 | 164 | 23 | 20360068 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | HNRNPDL FLNB RBM15 CCT3 MYO1E CORO1C SF3A1 PSMC1 DBT CIT TBL3 YARS1 EEF1B2 UBA1 TRMT6 AFG3L2 PPIE HADHA CTPS1 EXOSC7 HSPA5 SF3A2 TARS1 DYNC1H1 | 6.22e-09 | 1257 | 164 | 24 | 36526897 |
| Pubmed | CACNA2D1 TRAF3 NRCAM CCT3 CENPE NPEPPS CORO1C IQSEC2 NSD1 GRIA4 HCN2 SHTN1 CIT CYRIB UBA1 PPP2R5D IQSEC1 KIF4B RIMBP2 DYNC1H1 TP53BP2 | 6.23e-09 | 963 | 164 | 21 | 28671696 | |
| Pubmed | CCT3 NPEPPS CORO1C OLA1 PDIA3 CYRIB YARS1 EEF1B2 UBA1 HADHA CTPS1 HSPA5 DYNC1H1 | 6.53e-09 | 329 | 164 | 13 | 35562734 | |
| Pubmed | 7.10e-09 | 6 | 164 | 4 | 12527699 | ||
| Pubmed | FLNB FLNC CCT3 NPEPPS CBS PDIA3 YARS1 PDIA4 UBA1 HADHA CTPS1 HSPA5 TARS1 DYNC1H1 | 7.12e-09 | 397 | 164 | 14 | 21319273 | |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | FLNB FLNC RBM15 CCT3 NPEPPS SF3A1 NDUFS1 PDIA4 UBA1 HADHA CTPS1 HSPA1L HSPA2 HSPA5 DYNC1H1 | 9.39e-09 | 477 | 164 | 15 | 31300519 |
| Pubmed | CFH FLNB NRCAM MYO1E CORO1C IQSEC2 ASH1L PSMC1 SH3GLB2 GRIK1 SHTN1 CIT CBS YARS1 TMED4 SETDB1 RNF10 KDM4A ZBTB11 HSPA2 HSPA5 SF3A2 TARS1 DYNC1H1 | 9.48e-09 | 1285 | 164 | 24 | 35914814 | |
| Pubmed | CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer. | FLNB CCT3 NPEPPS CORO1C EEF1B2 UBA1 HADHA HSPA1L HSPA2 HSPA5 TARS1 DYNC1H1 | 1.42e-08 | 288 | 164 | 12 | 31501420 |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | FLNB MYH3 RNGTT CCT3 CENPE PCLO IQSEC2 PSMC1 TRMT6 AGL TBC1D14 BOD1L1 HADHA CTPS1 ZBTB11 CFAP44 HSPA5 DYNC1H1 | 1.45e-08 | 736 | 164 | 18 | 29676528 |
| Pubmed | TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex. | NPEPPS SF3A1 PDIA4 AGL HADHA CTPS1 ZBTB11 HSPA1L HSPA5 TARS1 | 1.50e-08 | 179 | 164 | 10 | 36261009 |
| Pubmed | Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics. | CCT3 CORO1C SF3A1 DBT PDIA3 PDIA4 PPP2R2C UBA1 PPP2R5D CSK HADHA CTPS1 CPVL HSPA1L DYNC1H1 TP53BP2 | 1.56e-08 | 573 | 164 | 16 | 28330616 |
| Pubmed | MET Inhibitors Promote Liver Tumor Evasion of the Immune Response by Stabilizing PDL1. | NPEPPS PSMC1 PDIA3 NDUFS1 YARS1 PDIA4 UBA1 HADHA CTPS1 HSPA5 | 1.76e-08 | 182 | 164 | 10 | 30711629 |
| Pubmed | HNRNPDL RNGTT MRPS28 CCT3 CORO1C SF3A1 PSMC1 OLA1 DBT CBS PDIA3 NDUFS1 EEF1B2 UBA1 AFG3L2 PPIE HADHA CTPS1 EXOSC7 CPVL HSPA1L HSPA2 HSPA5 TARS1 | 1.96e-08 | 1335 | 164 | 24 | 29229926 | |
| Pubmed | FLNB NRCAM CORO1C PCLO IQSEC2 PSMC1 GRIA4 DBT CIT NDUFS1 YARS1 NDUFV2 EEF1B2 UBA1 PPP2R5D AFG3L2 RNF10 IQSEC1 SYN2 HADHA HSPA2 AKAP7 | 2.31e-08 | 1139 | 164 | 22 | 36417873 | |
| Pubmed | RAD51 RBM15 CCT3 NPEPPS CORO1C SF3A1 OLA1 DBT TEAD3 CIT PDIA3 NDUFS1 EEF1B2 AFG3L2 PPIE HADHA NFAT5 HSPA5 SF3A2 TARS1 DYNC1H1 TNS3 TP53BP2 | 2.51e-08 | 1247 | 164 | 23 | 27684187 | |
| Pubmed | FLNB PSMC1 PDIA3 NDUFS1 TBL3 YARS1 PDIA4 UBA1 AGL AFG3L2 HADHA CTPS1 CPVL HSPA5 DYNC1H1 | 4.15e-08 | 534 | 164 | 15 | 35032548 | |
| Pubmed | DOCK1 FLNB CCT3 SF3A1 PSMC1 SHTN1 PDIA4 UBA1 PPP2R5D CSK AFG3L2 BOD1L1 HADHA CTPS1 HSPA5 TARS1 DYNC1H1 | 4.87e-08 | 708 | 164 | 17 | 39231216 | |
| Pubmed | HNRNPDL FLNB RBM15 CCT3 MYO1E NPEPPS OLA1 PDIA3 NDUFS1 TBL3 YARS1 PDIA4 EEF1B2 DDX46 OCIAD1 HSPA5 DYNC1H1 | 5.18e-08 | 711 | 164 | 17 | 33022573 | |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | HNRNPDL CCT3 SF3A1 PSMC1 CYRIB YARS1 EEF1B2 UBA1 PPIE HADHA CTPS1 HSPA1L HSPA2 HSPA5 SF3A2 TARS1 DYNC1H1 | 5.50e-08 | 714 | 164 | 17 | 28302793 |
| Pubmed | HNRNPDL RBM15 RNGTT CCT3 NPEPPS CORO1C SF3A1 PSMC1 OLA1 CIT PDIA3 PDIA4 EEF1B2 ARID1B UBA1 CDK13 HADHA CTPS1 SF3A2 TARS1 DYNC1H1 | 6.32e-08 | 1103 | 164 | 21 | 34189442 | |
| Pubmed | NPEPPS PSMC1 SHTN1 NDUFS1 TBL3 EXOC8 PPP2R5D HS2ST1 AFG3L2 TIMELESS HADHA CTPS1 CPVL HSPA5 DYNC1H1 | 7.70e-08 | 560 | 164 | 15 | 35241646 | |
| Pubmed | 1.03e-07 | 3 | 164 | 3 | 11551524 | ||
| Pubmed | LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. | FLNB CCT3 MYO1E CORO1C IQSEC2 PSMC1 PDIA3 PDIA4 UBA1 HS2ST1 MYO1F HADHA HSPA5 DYNC1H1 MYBPC2 | 1.21e-07 | 580 | 164 | 15 | 35676659 |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | HNRNPDL RBM15 RNGTT CCT3 NPEPPS PSMC1 QTRT2 CLPX CBS NDUFS1 TBL3 CYRIB EEF1B2 UBA1 AGL AFG3L2 HADHA CTPS1 HSPA2 HSPA5 TARS1 DYNC1H1 | 1.29e-07 | 1257 | 164 | 22 | 37317656 |
| Pubmed | FLNB CCT3 CORO1C SF3A1 SHTN1 UBA1 DDX46 CDK13 ASPM BOD1L1 PPIE HADHA SF3A2 DYNC1H1 | 1.44e-07 | 506 | 164 | 14 | 30890647 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | HNRNPDL RPGRIP1L MRPS28 CCT3 CENPE PCLO PSMC1 SH3GLB2 PEX13 DBT CLPX PDIA3 NDUFS1 TBL3 YARS1 NDUFV2 PDIA4 TRMT6 OCIAD1 CLYBL CDK13 AFG3L2 HADHA CPVL | 1.62e-07 | 1496 | 164 | 24 | 32877691 |
| Pubmed | HNRNPDL FLNB FLNC MRPS28 CCT3 CORO1C OLA1 NDUFS1 YARS1 NDUFV2 EEF1B2 SNX15 HADHA HSPA5 TARS1 DYNC1H1 | 2.73e-07 | 707 | 164 | 16 | 19738201 | |
| Pubmed | FLNC CCT3 MYO1E CLPX PDIA3 NDUFS1 PDIA4 HADHA NFAT5 HSPA5 DYNC1H1 | 3.09e-07 | 312 | 164 | 11 | 37120454 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | MYH2 FLNB FLNC RBM15 NPEPPS CORO1C SF3A1 PSMC1 DBT CLPX NDUFS1 TBL3 EXOC8 AFG3L2 RIMBP2 KDM4A HADHA SF3A2 AKAP7 | 3.13e-07 | 1005 | 164 | 19 | 19615732 |
| Pubmed | MYH2 FLNB CACNA2D1 TRAF3 MRPS28 CCT3 MYO1E NPEPPS PSMC1 QTRT2 CLPX PDIA3 NDUFS1 CYRIB EEF1B2 DDX46 AFG3L2 HADHA CTPS1 STX10 CPVL HSPA2 DYNC1H1 | 3.26e-07 | 1440 | 164 | 23 | 30833792 | |
| Pubmed | HNRNPDL FLNB CCT3 PSMC1 CBS NDUFS1 TBL3 UBA1 DDX46 HADHA CTPS1 HSPA2 HSPA5 TARS1 DYNC1H1 | 4.06e-07 | 638 | 164 | 15 | 33239621 | |
| Pubmed | 4.10e-07 | 4 | 164 | 3 | 8702974 | ||
| Pubmed | Comparative expression analysis of TEADs and their splice variants in mouse embryonic stem cells. | 4.10e-07 | 4 | 164 | 3 | 36516960 | |
| Pubmed | 4.10e-07 | 4 | 164 | 3 | 9889009 | ||
| Pubmed | The TEA domain: a novel, highly conserved DNA-binding motif. | 4.10e-07 | 4 | 164 | 3 | 2070413 | |
| Pubmed | 4.10e-07 | 4 | 164 | 3 | 9169843 | ||
| Pubmed | 4.10e-07 | 4 | 164 | 3 | 9502435 | ||
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | MYH2 FLNB MYH3 MYH13 NPEPPS PDIA3 NDUFS1 EXOC8 PDIA4 EEF1B2 UBA1 CTPS1 HSPA5 DYNC1H1 TNS3 | 4.84e-07 | 647 | 164 | 15 | 26618866 |
| Pubmed | HNRNPDL CCT3 OLA1 CBS PDIA3 PDIA4 UBA1 HADHA HSPA1L HSPA2 HSPA5 | 4.91e-07 | 327 | 164 | 11 | 34428256 | |
| Pubmed | FLNB FLNC RBM15 CCT3 NPEPPS SF3A1 NSD1 NDUFS1 TBL3 PDIA4 DDX46 HADHA ZBTB11 HSPA2 DYNC1H1 | 5.44e-07 | 653 | 164 | 15 | 22586326 | |
| Pubmed | Profiling of Parkin-binding partners using tandem affinity purification. | 5.71e-07 | 203 | 164 | 9 | 24244333 | |
| Pubmed | MYH2 FLNB FLNC CCT3 CLPX PDIA3 NDUFS1 YARS1 EEF1B2 CSK HADHA CTPS1 HSPA1L HSPA2 HSPA5 TARS1 DYNC1H1 | 5.75e-07 | 844 | 164 | 17 | 25963833 | |
| Pubmed | 6.58e-07 | 65 | 164 | 6 | 34645483 | ||
| Pubmed | Upregulation of RIN3 induces endosomal dysfunction in Alzheimer's disease. | POLR3K CCT3 NPEPPS EEF1B2 UBA1 CSK HADHA CTPS1 HSPA1L HSPA2 HSPA5 DYNC1H1 | 7.86e-07 | 418 | 164 | 12 | 32552912 |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | FLNB FLNC NPEPPS CORO1C SF3A1 CLPX YARS1 PDIA4 UBA1 HSPA1L DYNC1H1 | 8.08e-07 | 344 | 164 | 11 | 30333137 |
| Pubmed | HNRNPDL FLNB RBM15 RNGTT MRPS28 CCT3 SF3A1 PSMC1 CLPX EEF1B2 TRMT6 ASPM PPIE HADHA ZBTB11 EXOSC7 HSPA1L HSPA5 | 8.67e-07 | 971 | 164 | 18 | 33306668 | |
| Pubmed | Identification of Zika Virus and Dengue Virus Dependency Factors using Functional Genomics. | MYO1E NPEPPS SF3A1 DBT CLPX NDUFS1 TMED4 UBA1 DDX46 AGL AFG3L2 DYNC1H1 | 8.69e-07 | 422 | 164 | 12 | 27342126 |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | FLNB FLNC TRAF3 RNGTT NPEPPS PSMC1 QTRT2 PDIA3 EXOC8 PDIA4 EEF1B2 CSK PTPRR AGL AFG3L2 CPVL HSPA5 TNS3 | 9.06e-07 | 974 | 164 | 18 | 28675297 |
| Pubmed | 1.02e-06 | 5 | 164 | 3 | 8128486 | ||
| Pubmed | 1.02e-06 | 5 | 164 | 3 | 9671946 | ||
| Pubmed | 1.02e-06 | 5 | 164 | 3 | 21527258 | ||
| Pubmed | 1.02e-06 | 5 | 164 | 3 | 19324877 | ||
| Pubmed | 1.02e-06 | 5 | 164 | 3 | 22677547 | ||
| Pubmed | Flavin-Containing Monooxygenase 1 Catalyzes the Production of Taurine from Hypotaurine. | 1.02e-06 | 5 | 164 | 3 | 32156684 | |
| Pubmed | TEAD mediates YAP-dependent gene induction and growth control. | 1.02e-06 | 5 | 164 | 3 | 18579750 | |
| Pubmed | 1.02e-06 | 5 | 164 | 3 | 10518497 | ||
| Pubmed | Prdm3 and Prdm16 are H3K9me1 methyltransferases required for mammalian heterochromatin integrity. | 1.02e-06 | 5 | 164 | 3 | 22939622 | |
| Pubmed | 1.02e-06 | 5 | 164 | 3 | 8311461 | ||
| Pubmed | HNRNPDL CORO1C PSMC1 OLA1 PDIA3 NDUFS1 YARS1 TMED4 NDUFV2 PDIA4 EEF1B2 UBA1 HADHA CTPS1 CPVL DYNC1H1 | 1.10e-06 | 786 | 164 | 16 | 29128334 | |
| Pubmed | Mutual regulation between OGT and XIAP to control colon cancer cell growth and invasion. | HNRNPDL CCT3 PSMC1 SH3GLB2 OLA1 DBT CLPX PDIA3 YARS1 UBA1 TRMT6 HS2ST1 BEND7 HSPA5 SF3A2 | 1.38e-06 | 704 | 164 | 15 | 32994395 |
| Pubmed | HNRNPDL FLNB CCT3 CORO1C PSMC1 OLA1 PDIA3 NDUFS1 PDIA4 EEF1B2 UBA1 PPP2R5D HADHA CTPS1 HSPA5 DYNC1H1 | 1.45e-06 | 803 | 164 | 16 | 36517590 | |
| Pubmed | CCT3 NPEPPS CORO1C OLA1 CLPX SHTN1 CBS TBL3 YARS1 UBA1 HSPA5 TARS1 | 1.73e-06 | 451 | 164 | 12 | 36168627 | |
| Pubmed | Organization of human and mouse skeletal myosin heavy chain gene clusters is highly conserved. | 2.04e-06 | 6 | 164 | 3 | 10077619 | |
| Pubmed | 2.04e-06 | 6 | 164 | 3 | 11358867 | ||
| Pubmed | Histone H2A ubiquitination inhibits the enzymatic activity of H3 lysine 36 methyltransferases. | 2.04e-06 | 6 | 164 | 3 | 24019522 | |
| Pubmed | 2.04e-06 | 6 | 164 | 3 | 25995450 | ||
| Pubmed | 2.06e-06 | 237 | 164 | 9 | 29564676 | ||
| Pubmed | SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling. | HNRNPDL FLNC MYH13 CCT3 SF3A1 PSMC1 CIT EEF1B2 AFG3L2 CTPS1 CFAP44 HSPA5 DYNC1H1 | 2.74e-06 | 558 | 164 | 13 | 27591049 |
| Pubmed | Ski regulates Hippo and TAZ signaling to suppress breast cancer progression. | 3.01e-06 | 84 | 164 | 6 | 25670202 | |
| Pubmed | Reactive-site-centric chemoproteomics identifies a distinct class of deubiquitinase enzymes. | 3.01e-06 | 84 | 164 | 6 | 29563501 | |
| Pubmed | USP11 mediates repair of DNA-protein cross-links by deubiquitinating SPRTN metalloprotease. | RAD51 CCT3 NPEPPS PSMC1 DBT UBA1 AFG3L2 HADHA CTPS1 HSPA1L HSPA2 HSPA5 DYNC1H1 | 3.14e-06 | 565 | 164 | 13 | 33567341 |
| Pubmed | 3.55e-06 | 7 | 164 | 3 | 14736747 | ||
| Pubmed | 3.55e-06 | 7 | 164 | 3 | 35210422 | ||
| Pubmed | Tead proteins activate the Foxa2 enhancer in the node in cooperation with a second factor. | 3.55e-06 | 7 | 164 | 3 | 16207754 | |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | FLNB CCT3 NPEPPS CORO1C PSMC1 YARS1 UBA1 DDX46 CDK13 HADHA CTPS1 HSPA1L HSPA2 DYNC1H1 | 3.62e-06 | 665 | 164 | 14 | 30457570 |
| Pubmed | CCT3 NPEPPS CORO1C SH3GLB2 PDIA3 NDUFS1 UBA1 IQSEC1 SYN2 HSPA2 DYNC1H1 | 3.72e-06 | 403 | 164 | 11 | 30562941 | |
| Pubmed | 3.91e-06 | 50 | 164 | 5 | 23703321 | ||
| Pubmed | Cytokinesis involves a nontranscriptional function of the Hippo pathway effector YAP. | 3.94e-06 | 23 | 164 | 4 | 26933062 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | HNRNPDL RBM15 CCT3 SF3A1 PSMC1 DBT CLPX NDUFS1 TBL3 YARS1 STAT5A EEF1B2 DDX46 AFG3L2 IQSEC1 HADHA CTPS1 HSPA5 SF3A2 DYNC1H1 | 4.41e-06 | 1318 | 164 | 20 | 30463901 |
| Pubmed | Blocking an N-terminal acetylation-dependent protein interaction inhibits an E3 ligase. | FLNB CCT3 NPEPPS PSMC1 PDIA3 PDIA4 EEF1B2 UBA1 AGL HADHA CPVL HSPA5 | 4.49e-06 | 495 | 164 | 12 | 28581483 |
| Interaction | LINC01554 interactions | CCT3 PSMC1 OLA1 PDIA3 UBA1 DDX46 CTPS1 HSPA1L HSPA5 TARS1 DYNC1H1 | 1.60e-08 | 142 | 158 | 11 | int:LINC01554 |
| Interaction | KCTD13 interactions | FLNB CACNA2D1 FLNC NRCAM CCT3 MYO1E NPEPPS CORO1C PCLO IQSEC2 PSMC1 OLA1 CIT PDIA3 NDUFS1 CYRIB YARS1 NDUFV2 EEF1B2 PPP2R2C UBA1 AFG3L2 IQSEC1 SYN2 RIMBP2 HADHA HSPA1L HSPA2 HSPA5 TARS1 DYNC1H1 TP53BP2 | 3.14e-08 | 1394 | 158 | 32 | int:KCTD13 |
| Interaction | YAP1 interactions | FLNB TEAD2 CCT3 NPEPPS CORO1C SF3A1 NSD1 TEAD4 TEAD3 SHTN1 CIT PDIA3 EEF1B2 ARID1B UBA1 DDX46 BOD1L1 HADHA NFAT5 CPVL HSPA1L HSPA2 HSPA5 TARS1 DYNC1H1 TP53BP2 | 3.99e-07 | 1095 | 158 | 26 | int:YAP1 |
| Interaction | AIMP2 interactions | FLNB FLNC CCT3 NPEPPS AP1M2 DBT CBS PDIA3 EXOC8 UBA1 CSK KDR CTPS1 HSPA1L HSPA2 HSPA5 | 4.70e-07 | 446 | 158 | 16 | int:AIMP2 |
| Interaction | SERBP1 interactions | FLNB RBM15 CCT3 NPEPPS PCLO PSMC1 SH3GLB2 QTRT2 CIT CBS PDIA3 NDUFS1 CYRIB YARS1 EXOC8 PDIA4 EEF1B2 PPP2R2C UBA1 TRMT6 PPP2R5D FBP1 CSK CDK13 RNF10 HADHA CTPS1 HSPA5 TARS1 DYNC1H1 | 6.51e-07 | 1432 | 158 | 30 | int:SERBP1 |
| Interaction | DNASE1L2 interactions | 1.30e-06 | 25 | 158 | 5 | int:DNASE1L2 | |
| Interaction | PLOD2 interactions | 1.61e-06 | 180 | 158 | 10 | int:PLOD2 | |
| Interaction | RNF123 interactions | FLNB MYH3 FLNC RNGTT CCT3 CENPE PCLO IQSEC2 PSMC1 GRIK1 TRMT6 AGL TBC1D14 BOD1L1 HADHA CTPS1 ZBTB11 CFAP44 HSPA1L HSPA5 DYNC1H1 | 1.97e-06 | 824 | 158 | 21 | int:RNF123 |
| Interaction | PRC1 interactions | HNRNPDL FLNB FLNC RBM15 CCT3 MYO1E CENPE CORO1C SF3A1 CIT PDIA3 NDUFS1 TBL3 DDX46 MYO1F KIF4B PPIE HADHA EXOSC7 SF3A2 DYNC1H1 MYBPC1 PDZD2 | 2.19e-06 | 973 | 158 | 23 | int:PRC1 |
| Interaction | CUL7 interactions | HNRNPDL FLNB RBM15 CCT3 NPEPPS CORO1C SF3A1 OLA1 CIT PDIA3 TBL3 PDIA4 EEF1B2 UBA1 DDX46 HADHA HSPA1L HSPA5 SF3A2 TARS1 DYNC1H1 | 2.92e-06 | 845 | 158 | 21 | int:CUL7 |
| Interaction | HDAC6 interactions | FLNB CCT3 MYO1E KMT5A CORO1C SF3A1 IQSEC2 PSMC1 DBT PDIA3 PDIA4 EEF1B2 UBA1 FBP1 HS2ST1 MYO1F HADHA HSPA1L HSPA2 HSPA5 DYNC1H1 MYBPC2 | 3.62e-06 | 929 | 158 | 22 | int:HDAC6 |
| Interaction | AGR2 interactions | FLNB FLNC CCT3 NPEPPS CORO1C PCLO ASH1L NSD1 AP1M2 OLA1 PDIA3 CYRIB PDIA4 EEF1B2 ARID1B FBP1 HADHA HSPA1L HSPA2 HSPA5 TARS1 DYNC1H1 | 3.95e-06 | 934 | 158 | 22 | int:AGR2 |
| Interaction | RSPH6A interactions | 6.44e-06 | 34 | 158 | 5 | int:RSPH6A | |
| Interaction | OBSL1 interactions | HNRNPDL PRUNE2 FLNB FLNC RBM15 MRPS28 CCT3 CORO1C SF3A1 PCLO GRIK1 CIT PDIA3 TBL3 PDIA4 UBA1 DDX46 EXOSC7 HSPA5 SF3A2 DYNC1H1 | 7.99e-06 | 902 | 158 | 21 | int:OBSL1 |
| Interaction | PLRG1 interactions | 8.17e-06 | 216 | 158 | 10 | int:PLRG1 | |
| Interaction | TFCP2 interactions | FLNB TEAD2 CCT3 NPEPPS CORO1C SHTN1 EEF1B2 UBA1 HADHA HSPA1L HSPA2 HSPA5 TARS1 DYNC1H1 | 9.02e-06 | 436 | 158 | 14 | int:TFCP2 |
| Interaction | CCDC90B interactions | 1.08e-05 | 223 | 158 | 10 | int:CCDC90B | |
| Interaction | SRSF9 interactions | HNRNPDL FLNC KMT5A SF3A1 MECOM CIT EEF1B2 PPIE SF3A2 DYNC1H1 | 1.12e-05 | 224 | 158 | 10 | int:SRSF9 |
| Interaction | METTL21C interactions | 1.29e-05 | 19 | 158 | 4 | int:METTL21C | |
| Interaction | ISY1-RAB43 interactions | 1.29e-05 | 39 | 158 | 5 | int:ISY1-RAB43 | |
| Interaction | BIRC3 interactions | HNRNPDL FLNB RBM15 TRAF3 CCT3 NPEPPS CORO1C SF3A1 PSMC1 OLA1 DBT CLPX CBS PDIA3 NDUFS1 TBL3 YARS1 PDIA4 EEF1B2 UBA1 HADHA CTPS1 HSPA5 TARS1 DYNC1H1 MYBPC1 | 1.47e-05 | 1334 | 158 | 26 | int:BIRC3 |
| Interaction | HYDIN interactions | 1.96e-05 | 21 | 158 | 4 | int:HYDIN | |
| Interaction | TRAP1 interactions | MRPS28 SF3A1 DBT CLPX CIT CBS PDIA3 NDUFV2 DDX46 AFG3L2 HADHA HSPA5 SF3A2 DYNC1H1 | 1.99e-05 | 468 | 158 | 14 | int:TRAP1 |
| Interaction | CEBPB interactions | RAD51 HNRNPDL FLNB CCT3 NPEPPS SF3A1 PSMC1 TEAD4 OLA1 PDIA3 YARS1 STAT5A PDIA4 EEF1B2 UBA1 DDX46 CDK13 ASPM HADHA ATOX1 CTPS1 NFAT5 HSPA5 SF3A2 TARS1 DYNC1H1 TNS3 | 2.04e-05 | 1443 | 158 | 27 | int:CEBPB |
| Interaction | HOOK1 interactions | 2.04e-05 | 240 | 158 | 10 | int:HOOK1 | |
| Interaction | EFTUD2 interactions | HNRNPDL FLNB MRPS28 CCT3 MYO1E SF3A1 PSMC1 SH3GLB2 OLA1 CLPX CIT CBS PDIA3 YARS1 EEF1B2 UBA1 PPP2R5D CDK13 AFG3L2 PPIE HADHA CTPS1 EXOSC7 HSPA5 SF3A2 TARS1 DYNC1H1 | 2.19e-05 | 1449 | 158 | 27 | int:EFTUD2 |
| Interaction | CNTRL interactions | 2.21e-05 | 193 | 158 | 9 | int:CNTRL | |
| Interaction | USP11 interactions | TEAD2 CCT3 CENPE NPEPPS CORO1C NDUFS1 TBL3 NDUFV2 SETDB1 UBA1 CTPS1 HSPA1L HSPA2 HSPA5 DYNC1H1 | 2.32e-05 | 539 | 158 | 15 | int:USP11 |
| Interaction | FBXO43 interactions | 2.52e-05 | 74 | 158 | 6 | int:FBXO43 | |
| Interaction | LONP1 interactions | FLNC RPGRIP1L MRPS28 CCT3 CORO1C CLPX CIT NDUFS1 YARS1 NDUFV2 PPP2R2C OCIAD1 AFG3L2 DYNC1H1 | 2.57e-05 | 479 | 158 | 14 | int:LONP1 |
| Interaction | PTPRR interactions | 2.58e-05 | 110 | 158 | 7 | int:PTPRR | |
| Interaction | MYBPC2 interactions | 2.64e-05 | 45 | 158 | 5 | int:MYBPC2 | |
| Interaction | BAP1 interactions | HNRNPDL FLNB FLNC MRPS28 CCT3 NPEPPS CORO1C SF3A1 PSMC1 SHTN1 PDIA3 YARS1 PDIA4 EEF1B2 UBA1 DDX46 AGL HADHA CTPS1 CPVL HSPA1L HSPA2 HSPA5 TARS1 DYNC1H1 | 3.28e-05 | 1314 | 158 | 25 | int:BAP1 |
| Interaction | ACTC1 interactions | FLNB CCT3 CORO1C SF3A1 SHTN1 CIT ARID1B UBA1 DDX46 FBP1 CDK13 ASPM BOD1L1 PPIE HADHA SF3A2 DYNC1H1 | 3.31e-05 | 694 | 158 | 17 | int:ACTC1 |
| Interaction | COLGALT1 interactions | 3.56e-05 | 158 | 158 | 8 | int:COLGALT1 | |
| Interaction | BAG1 interactions | HNRNPDL CCT3 SF3A1 PSMC1 OLA1 CBS PDIA3 PDIA4 UBA1 HADHA HSPA1L HSPA2 HSPA5 SF3A2 | 3.60e-05 | 494 | 158 | 14 | int:BAG1 |
| Interaction | FMO2 interactions | 3.84e-05 | 9 | 158 | 3 | int:FMO2 | |
| Interaction | BRCA1 interactions | RAD51 HNRNPDL FLNB FLNC RNGTT CCT3 NPEPPS SF3A1 SYT6 PSMC1 OLA1 CLPX CIT TBL3 STAT5A PDIA4 EEF1B2 UBA1 AGL CTPS1 HSPA1L HSPA5 TARS1 DYNC1H1 | 4.11e-05 | 1249 | 158 | 24 | int:BRCA1 |
| Interaction | DHX15 interactions | HNRNPDL FLNB RBM15 SF3A1 PSMC1 MECOM CIT DDX46 FBP1 PPIE HSPA2 HSPA5 SF3A2 DYNC1H1 | 4.28e-05 | 502 | 158 | 14 | int:DHX15 |
| Interaction | DDX39B interactions | RBM15 CCT3 MYO1E CORO1C SF3A1 CIT PDIA3 NDUFS1 PDIA4 EEF1B2 IQSEC1 HADHA HSPA5 SF3A2 DYNC1H1 | 4.40e-05 | 570 | 158 | 15 | int:DDX39B |
| Interaction | SEPTIN9 interactions | 4.73e-05 | 265 | 158 | 10 | int:SEPTIN9 | |
| Interaction | FMO5 interactions | 5.45e-05 | 10 | 158 | 3 | int:FMO5 | |
| Interaction | ZNF181 interactions | 5.45e-05 | 10 | 158 | 3 | int:ZNF181 | |
| Interaction | GARS1 interactions | HNRNPDL FLNB RPGRIP1L CORO1C PDIA3 UBA1 AGL HSPA2 HSPA5 TARS1 | 5.54e-05 | 270 | 158 | 10 | int:GARS1 |
| Interaction | ITGB3 interactions | 5.98e-05 | 170 | 158 | 8 | int:ITGB3 | |
| Interaction | CIT interactions | RAD51 HNRNPDL FLNB FLNC RBM15 CCT3 MYO1E NPEPPS CORO1C SF3A1 PCLO ASH1L CLPX CIT TBL3 EEF1B2 UBA1 DDX46 PAX8 BOD1L1 HADHA HSPA1L HSPA2 HSPA5 SF3A2 DYNC1H1 | 6.06e-05 | 1450 | 158 | 26 | int:CIT |
| Interaction | STK32C interactions | 6.32e-05 | 87 | 158 | 6 | int:STK32C | |
| Interaction | SUMO2 interactions | RAD51 FLNB CCT3 SF3A1 PSMC1 TEAD3 PDIA3 PDIA4 SETDB1 UBA1 BOD1L1 PPIE HSPA5 DYNC1H1 TP53BP2 | 6.61e-05 | 591 | 158 | 15 | int:SUMO2 |
| Interaction | RBM39 interactions | HNRNPDL MRPS28 CCT3 SF3A1 PSMC1 MECOM CIT CYRIB YARS1 EEF1B2 UBA1 FBP1 PPIE HADHA CTPS1 HSPA1L HSPA2 HSPA5 SF3A2 TARS1 DYNC1H1 | 6.68e-05 | 1042 | 158 | 21 | int:RBM39 |
| Interaction | ZUP1 interactions | 7.05e-05 | 174 | 158 | 8 | int:ZUP1 | |
| Interaction | RIN3 interactions | POLR3K CCT3 NPEPPS EEF1B2 UBA1 CSK ASPM HADHA CTPS1 HSPA1L HSPA2 HSPA5 DYNC1H1 | 7.57e-05 | 463 | 158 | 13 | int:RIN3 |
| Interaction | SNW1 interactions | DOCK1 RBM15 CCT3 SF3A1 PSMC1 OLA1 CIT UBA1 TRMT6 DDX46 CSK PPIE EXOSC7 HSPA1L HSPA2 HSPA5 SF3A2 | 8.20e-05 | 747 | 158 | 17 | int:SNW1 |
| Interaction | LRPPRC interactions | HNRNPDL RNGTT MRPS28 CENPE CORO1C PSMC1 DBT CLPX CIT NDUFS1 NDUFV2 FBP1 PTPRR AFG3L2 ASPM PPIE HADHA HSPA5 | 8.84e-05 | 827 | 158 | 18 | int:LRPPRC |
| Interaction | PINK1 interactions | FLNB FLNC RBM15 TRAF3 CCT3 NPEPPS SF3A1 NDUFS1 PDIA4 UBA1 HADHA CTPS1 HSPA1L HSPA2 HSPA5 DYNC1H1 | 8.97e-05 | 679 | 158 | 16 | int:PINK1 |
| Interaction | C9orf72 interactions | HNRNPDL RBM15 RNGTT CCT3 DNAJC25 NPEPPS PSMC1 QTRT2 CLPX CBS NDUFS1 TBL3 CYRIB EEF1B2 UBA1 OCIAD1 AGL AFG3L2 HADHA CTPS1 HSPA2 HSPA5 TARS1 DYNC1H1 | 9.64e-05 | 1319 | 158 | 24 | int:C9orf72 |
| Interaction | ETFBKMT interactions | 9.70e-05 | 31 | 158 | 4 | int:ETFBKMT | |
| Interaction | RICTOR interactions | FLNB FLNC CCT3 MYO1E KMT5A SF3A1 SH3GLB2 CLPX PDIA3 NDUFS1 PDIA4 UBA1 DDX46 HADHA NFAT5 HSPA5 DYNC1H1 | 9.95e-05 | 759 | 158 | 17 | int:RICTOR |
| Interaction | EMC2 interactions | DNAJC25 CORO1C SF3A1 DBT NDUFS1 TMED4 NDUFV2 DDX46 AGL HADHA HSPA5 SF3A2 | 9.98e-05 | 411 | 158 | 12 | int:EMC2 |
| Interaction | SLC25A3 interactions | FLNC CCT3 CIT NDUFS1 TMED4 NDUFV2 PPP2R2C CSK AFG3L2 HADHA HSPA1L HSPA5 | 9.98e-05 | 411 | 158 | 12 | int:SLC25A3 |
| Interaction | CHMP4C interactions | HNRNPDL FLNB FLNC MYO1E NPEPPS CORO1C SF3A1 PDIA3 TBL3 CYRIB YARS1 PDIA4 EEF1B2 CSK HSPA1L TARS1 | 1.03e-04 | 687 | 158 | 16 | int:CHMP4C |
| Interaction | RECQL4 interactions | HNRNPDL RNGTT MRPS28 CCT3 CORO1C SF3A1 PSMC1 OLA1 DBT CBS PDIA3 NDUFS1 EEF1B2 UBA1 AFG3L2 PPIE TIMELESS HADHA CTPS1 EXOSC7 CPVL HSPA1L HSPA2 HSPA5 TARS1 | 1.05e-04 | 1412 | 158 | 25 | int:RECQL4 |
| Interaction | NPHP4 interactions | 1.05e-04 | 236 | 158 | 9 | int:NPHP4 | |
| Interaction | CEBPA interactions | HNRNPDL RBM15 RNGTT CCT3 NPEPPS CORO1C SF3A1 PSMC1 OLA1 DBT CIT PDIA3 PDIA4 EEF1B2 ARID1B UBA1 CDK13 HADHA CTPS1 HSPA5 SF3A2 TARS1 DYNC1H1 | 1.09e-04 | 1245 | 158 | 23 | int:CEBPA |
| Interaction | MCM2 interactions | MYH2 FLNB FLNC RNGTT CCT3 SF3A1 CLPX PDIA3 NDUFS1 YARS1 PDIA4 EEF1B2 CSK TIMELESS HADHA CTPS1 HSPA1L HSPA2 HSPA5 TARS1 DYNC1H1 | 1.12e-04 | 1081 | 158 | 21 | int:MCM2 |
| Interaction | C9orf78 interactions | NPEPPS PSMC1 SHTN1 NDUFS1 TBL3 EXOC8 PPP2R5D HS2ST1 AFG3L2 TIMELESS HADHA CTPS1 CPVL HSPA5 DYNC1H1 | 1.13e-04 | 620 | 158 | 15 | int:C9orf78 |
| Interaction | STIP1 interactions | HNRNPDL FLNB CCT3 PSMC1 SH3GLB2 OLA1 CBS NDUFS1 TBL3 UBA1 DDX46 CSK HADHA CTPS1 HSPA1L HSPA2 HSPA5 TARS1 DYNC1H1 TNS3 | 1.21e-04 | 1006 | 158 | 20 | int:STIP1 |
| Interaction | FZR1 interactions | HNRNPDL FLNB TEAD2 RBM15 RNGTT MRPS28 CCT3 KMT5A SF3A1 PSMC1 CLPX EEF1B2 TRMT6 ASPM PPIE HADHA ZBTB11 EXOSC7 HSPA1L HSPA2 HSPA5 MYBPC2 | 1.25e-04 | 1172 | 158 | 22 | int:FZR1 |
| Interaction | MECOM interactions | MYH2 FLNC RBM15 PSMC1 MECOM TBL3 ARID1B HADHA CTPS1 DYNC1H1 MYBPC2 | 1.25e-04 | 358 | 158 | 11 | int:MECOM |
| Interaction | DYSF interactions | 1.25e-04 | 62 | 158 | 5 | int:DYSF | |
| Interaction | SMOX interactions | 1.28e-04 | 13 | 158 | 3 | int:SMOX | |
| Interaction | OPTN interactions | HNRNPDL MYH3 TRAF3 QTRT2 CBS YARS1 EEF1B2 PPP2R5D OCIAD1 AFG3L2 HADHA DYNC1H1 | 1.28e-04 | 422 | 158 | 12 | int:OPTN |
| Interaction | MTRF1 interactions | 1.31e-04 | 243 | 158 | 9 | int:MTRF1 | |
| Interaction | WDR5 interactions | HNRNPDL FLNB RBM15 TRAF3 CCT3 MYO1E NPEPPS OLA1 CIT PDIA3 NDUFS1 TBL3 YARS1 PDIA4 EEF1B2 DDX46 OCIAD1 IQSEC1 BOD1L1 HSPA5 DYNC1H1 | 1.44e-04 | 1101 | 158 | 21 | int:WDR5 |
| Interaction | KIF23 interactions | HNRNPDL FLNB RPGRIP1L MYO1E CORO1C PCLO NSD1 PSMC1 CLPX CIT CBS PDIA3 TBL3 MYO1F ASPM HADHA ATOX1 CTPS1 HSPA5 DYNC1H1 | 1.68e-04 | 1031 | 158 | 20 | int:KIF23 |
| Interaction | OTC interactions | 1.70e-04 | 104 | 158 | 6 | int:OTC | |
| Interaction | METTL21A interactions | 1.76e-04 | 36 | 158 | 4 | int:METTL21A | |
| Interaction | CUL1 interactions | RAD51 DOCK1 HNRNPDL MYH3 MYO1E CENPE KMT5A CLPX EEF1B2 OCIAD1 ZNRF3 AGL KDR KDM4A CTPS1 HSPA1L HSPA5 TARS1 | 1.81e-04 | 876 | 158 | 18 | int:CUL1 |
| Interaction | MST1R interactions | 1.85e-04 | 200 | 158 | 8 | int:MST1R | |
| Interaction | MSH2 interactions | RAD51 TRAF3 RPGRIP1L SF3A1 AP1M2 MECOM UBA1 TRMT6 FBP1 HSPA5 | 1.87e-04 | 313 | 158 | 10 | int:MSH2 |
| Interaction | UTS2 interactions | 2.01e-04 | 15 | 158 | 3 | int:UTS2 | |
| Interaction | AAR2 interactions | FLNB CCT3 SF3A1 CIT CBS PDIA3 EEF1B2 UBA1 DDX46 KDR HADHA CTPS1 HSPA5 TARS1 DYNC1H1 | 2.11e-04 | 657 | 158 | 15 | int:AAR2 |
| Interaction | AHNAK interactions | 2.12e-04 | 318 | 158 | 10 | int:AHNAK | |
| Interaction | MTNAP1 interactions | 2.18e-04 | 260 | 158 | 9 | int:MTNAP1 | |
| Interaction | FGD5 interactions | 2.34e-04 | 207 | 158 | 8 | int:FGD5 | |
| Interaction | COX4I1 interactions | MRPS28 CORO1C DBT CLPX PDIA3 NDUFS1 NDUFV2 PDIA4 OCIAD1 AFG3L2 HADHA HSPA5 | 2.41e-04 | 452 | 158 | 12 | int:COX4I1 |
| Interaction | TRIM33 interactions | NPEPPS SF3A1 DBT PDIA4 ARID1B AGL HADHA CTPS1 ZBTB11 HSPA1L HSPA5 TARS1 | 2.46e-04 | 453 | 158 | 12 | int:TRIM33 |
| Interaction | STK4 interactions | 2.63e-04 | 159 | 158 | 7 | int:STK4 | |
| Interaction | CDC34 interactions | NPEPPS TBL3 UBA1 DDX46 AFG3L2 HADHA HSPA2 HSPA5 TARS1 DYNC1H1 | 2.71e-04 | 328 | 158 | 10 | int:CDC34 |
| Interaction | CRYZ interactions | 2.73e-04 | 160 | 158 | 7 | int:CRYZ | |
| Interaction | VGLL1 interactions | 2.97e-04 | 17 | 158 | 3 | int:VGLL1 | |
| Interaction | RTF2 interactions | 3.08e-04 | 75 | 158 | 5 | int:RTF2 | |
| Interaction | REXO2 interactions | 3.23e-04 | 42 | 158 | 4 | int:REXO2 | |
| Interaction | KDM4C interactions | 3.28e-04 | 76 | 158 | 5 | int:KDM4C | |
| Interaction | SQSTM1 interactions | RAD51 FLNB TRAF3 MRPS28 CCT3 ENPP1 PSMC1 MECOM CIT PDIA3 STAT5A UBA1 PPP2R5D OCIAD1 HS2ST1 IQSEC1 KDR HADHA CTPS1 HSPA5 DYNC1H1 TP53BP2 | 3.33e-04 | 1257 | 158 | 22 | int:SQSTM1 |
| Interaction | TUFM interactions | HNRNPDL MRPS28 CORO1C MECOM DBT CLPX CIT NDUFS1 NDUFV2 PDIA4 PPP2R2C FBP1 AFG3L2 HADHA HSPA2 | 3.35e-04 | 686 | 158 | 15 | int:TUFM |
| Interaction | NUDC interactions | HNRNPDL FLNB FLNC TRAF3 CORO1C PDIA4 DDX46 BOD1L1 TARS1 DYNC1H1 | 3.36e-04 | 337 | 158 | 10 | int:NUDC |
| Interaction | SLIRP interactions | 3.44e-04 | 338 | 158 | 10 | int:SLIRP | |
| Interaction | HSP90AA1 interactions | RAD51 TBX22 TEAD2 CIT SETDB1 UBA1 DDX46 CSK CDK13 AFG3L2 RNF10 KDR BOD1L1 PPIE HADHA HSPA1L HSPA2 HSPA5 PRKX TARS1 DYNC1H1 EPHB1 | 3.56e-04 | 1263 | 158 | 22 | int:HSP90AA1 |
| Interaction | FN1 interactions | HNRNPDL FLNB FLNC MRPS28 CCT3 CORO1C TEAD4 OLA1 YARS1 STAT5A NDUFV2 EEF1B2 SNX15 HADHA HSPA5 TARS1 DYNC1H1 | 3.67e-04 | 848 | 158 | 17 | int:FN1 |
| Interaction | NMD3 interactions | 3.70e-04 | 120 | 158 | 6 | int:NMD3 | |
| Cytoband | 1q24.3 | 4.79e-05 | 20 | 163 | 3 | 1q24.3 | |
| Cytoband | 7q34 | 3.40e-04 | 167 | 163 | 5 | 7q34 | |
| GeneFamily | TEA domain transcription factors | 1.05e-06 | 4 | 117 | 3 | 1183 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 2.49e-06 | 34 | 117 | 5 | 487 | |
| GeneFamily | Myosin heavy chains | 1.14e-04 | 15 | 117 | 3 | 1098 | |
| GeneFamily | Heat shock 70kDa proteins | 1.68e-04 | 17 | 117 | 3 | 583 | |
| GeneFamily | T cell receptor beta locus at 7q34 | 2.52e-04 | 87 | 117 | 5 | 372 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 6.30e-04 | 161 | 117 | 6 | 593 | |
| GeneFamily | Fibronectin type III domain containing|I-set domain containing|Myosin binding proteins | 1.13e-03 | 8 | 117 | 2 | 658 | |
| GeneFamily | Myosins, class I | 1.13e-03 | 8 | 117 | 2 | 1097 | |
| GeneFamily | Cyclic nucleotide gated channels | 1.81e-03 | 10 | 117 | 2 | 250 | |
| GeneFamily | NADH:ubiquinone oxidoreductase core subunits | 3.59e-03 | 14 | 117 | 2 | 1149 | |
| GeneFamily | Zinc fingers|Zinc fingers PARP-type|Poly(ADP-ribose) polymerases | 4.13e-03 | 15 | 117 | 2 | 26 | |
| GeneFamily | WD repeat domain containing|Protein phosphatase 2 regulatory subunits | 4.13e-03 | 15 | 117 | 2 | 696 | |
| GeneFamily | AAA ATPases | 4.89e-03 | 53 | 117 | 3 | 413 | |
| GeneFamily | Synaptotagmins | 5.30e-03 | 17 | 117 | 2 | 765 | |
| Coexpression | GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_MAC_DN | 4.30e-06 | 200 | 161 | 9 | M5262 | |
| Coexpression | KYNG_DNA_DAMAGE_BY_UV | 2.04e-05 | 54 | 161 | 5 | M17866 | |
| Coexpression | ERBB2_UP.V1_DN | 3.11e-05 | 197 | 161 | 8 | M2635 | |
| Coexpression | GSE11961_MARGINAL_ZONE_BCELL_VS_GERMINAL_CENTER_BCELL_DAY7_UP | 3.34e-05 | 199 | 161 | 8 | M9320 | |
| Coexpression | GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_MAC_DN | 3.34e-05 | 199 | 161 | 8 | M5257 | |
| ToppCell | COVID-19-kidney-Stressed_PCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.59e-07 | 181 | 163 | 8 | 6980ea624151da32b7f537f263e40fcb87a02e81 | |
| ToppCell | Mild_COVID-19-Epithelial-AT1/AT2|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 4.23e-07 | 185 | 163 | 8 | c55fdba1e3818ec0404d7ab473bf18dd25f2bb0a | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.41e-07 | 186 | 163 | 8 | c116cc9f41971622264434ebe29d18e719b0ae19 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-Mesoderm|6m / Sample Type, Dataset, Time_group, and Cell type. | 7.64e-07 | 200 | 163 | 8 | 0f6851baf0cf2a8b0c95a7a585c4407c330c5f6c | |
| ToppCell | PCW_13-14-Neuronal-Neuronal_postreplicative-neuro_immature_neuronal_(2)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.20e-06 | 161 | 163 | 7 | bb9cb42882aaa4a1ecf9b480c0e7ac302f2c0d5d | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_B-Branch_B3_(IPAN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.50e-06 | 185 | 163 | 7 | edb114487206e4e8df4c7878285df40f49b7fd64 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 6.11e-06 | 188 | 163 | 7 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | Control-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 7.02e-06 | 192 | 163 | 7 | 7e89b9125e8b85f6be85eeccef5c8644647ab0e1 | |
| ToppCell | P15-Endothelial-large_vessel_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.26e-06 | 193 | 163 | 7 | 5f9a7cd5f8eb9ac294cdb50518fedf872f3f78f5 | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating|367C / Donor, Lineage, Cell class and subclass (all cells) | 7.51e-06 | 194 | 163 | 7 | a12b64945e10f00aa983678a02586c59badc1570 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.76e-06 | 195 | 163 | 7 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area|World / Primary Cells by Cluster | 8.30e-06 | 197 | 163 | 7 | 79b9e7f2e8e33b3c547f716be5667156c48b0dfc | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area-33|World / Primary Cells by Cluster | 8.30e-06 | 197 | 163 | 7 | d20f29088e9afd8a960d6f680075c380e550f8a7 | |
| ToppCell | megakaryocytic-CD34+_Megakaryoblast|megakaryocytic / Lineage and Cell class | 8.86e-06 | 199 | 163 | 7 | 99a65887d3c8a2cde26693dd74404b101bba9d58 | |
| ToppCell | Transverse-Dendritic_cell-cycling_DCs|Transverse / Region, Cell class and subclass | 9.15e-06 | 200 | 163 | 7 | f588d8889f351c797963616a3575fa43efd46b9a | |
| ToppCell | Transverse-(5)_Dendritic_cell-(52)_cycling_DCs|Transverse / shred on region, Cell_type, and subtype | 9.15e-06 | 200 | 163 | 7 | 51e643d48b5e97a0e117b578a6ea7d429c6cdd1e | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.31e-05 | 155 | 163 | 6 | 8e239470799426ea474a36f57e1b7e0d9365ca5f | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.17e-05 | 164 | 163 | 6 | 382e42701779d12a7948690b3be72d06dd75c8b4 | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.39e-05 | 166 | 163 | 6 | 575c325db88d6909cdf0d5e664bd9098b89d4401 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.51e-05 | 167 | 163 | 6 | f01b96173deda0239fa482989873cf308e49d48c | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.51e-05 | 167 | 163 | 6 | 5fc85a05124cd2324e1b8ff940193880f83cd8af | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.51e-05 | 167 | 163 | 6 | 3c06894fc6177f3c204094719904da42f08b9af8 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.63e-05 | 168 | 163 | 6 | fa0d251693935116adf633d02b7ec4a295100865 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Endocervical_Adenocarcinoma|TCGA-Cervix / Sample_Type by Project: Shred V9 | 3.87e-05 | 170 | 163 | 6 | d682178d11d67eb5a02d0c6b3967645e37bcc62a | |
| ToppCell | droplet-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l7|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.55e-05 | 175 | 163 | 6 | 7be76d39e1a4f4ac709672cd2d409a2523a083ce | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-cDC1|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.70e-05 | 176 | 163 | 6 | 87f90834c7278516beff7814b78f7c75732d9bf0 | |
| ToppCell | COVID-19-kidney-Distal_Epi_Doublet_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type | 4.70e-05 | 176 | 163 | 6 | 36f77d878a53b30465b0dea8333a3865dba75613 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-neuro-epithelial-M/X_cells_(MLN/GHRL+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.49e-05 | 181 | 163 | 6 | af031661af28f99d906d8e013b4949133b44a2e6 | |
| ToppCell | Epithelial-lung_neuroendocrine_cell_(PNEC)|World / Lineage, Cell type, age group and donor | 5.66e-05 | 182 | 163 | 6 | 57bf4ffb304324e2e392e196336a530d9f78fe0d | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.66e-05 | 182 | 163 | 6 | a05e5978ef5f7fac7eeb2ba1c0103ea90d5e9136 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-OPC|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.66e-05 | 182 | 163 | 6 | 831b5ce46b41efe01c4db6016c2f43148611373d | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.66e-05 | 182 | 163 | 6 | c7f2d24697affa530b748ab32b1d40bdc1bdc20a | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.66e-05 | 182 | 163 | 6 | d95635b74e8cd8bc00bfe40340806b59fb9bee43 | |
| ToppCell | facs-Marrow-T-cells-3m-Hematologic-Unknown_Progenitor|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.84e-05 | 183 | 163 | 6 | b0b835f3b1de1bd46a47e1b805aa8994cd3a4e3e | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.84e-05 | 183 | 163 | 6 | 92fbd83a9d13ee91065cbd479fb298f1fd564568 | |
| ToppCell | Cerebellum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1-MURAL_Mural.Acta2Rgs5.Acta2_(Mural.Acta2Rgs5.Acta2)-|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 6.01e-05 | 113 | 163 | 5 | 7c5317bda7f13649af4837ca717dfdad74152f8f | |
| ToppCell | Cerebellum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1-MURAL_Mural.Acta2Rgs5.Acta2_(Mural.Acta2Rgs5.Acta2)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 6.01e-05 | 113 | 163 | 5 | 3c745f4d975475860e793f304a846b032515b334 | |
| ToppCell | Cerebellum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 6.01e-05 | 113 | 163 | 5 | d67022ae14fae91f9f21ebe8c6ab6d8d6d725bc4 | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.02e-05 | 184 | 163 | 6 | 087666ba949b129c53d7ace40f9e543e3875a7de | |
| ToppCell | LPS-IL1RA|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.02e-05 | 184 | 163 | 6 | c066c2ec4f0f1d6eb183fca5c7bb0cd45c9950dc | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.02e-05 | 184 | 163 | 6 | 6b0c110d8930df99043c3b99cf4d873985126960 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.02e-05 | 184 | 163 | 6 | 35928fc5f7bbf8c7b09181a2bd27e22dff42ec16 | |
| ToppCell | URO-Myeloid-pDC|URO / Disease, Lineage and Cell Type | 6.02e-05 | 184 | 163 | 6 | 0edb5dd003c2bca0b9e3ec18d03610d68bd52538 | |
| ToppCell | droplet-Lung-nan-21m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.39e-05 | 186 | 163 | 6 | 5d0cd07b6b51e8ce9e1da949f757dc4575ec5752 | |
| ToppCell | droplet-Lung-LUNG-1m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.39e-05 | 186 | 163 | 6 | 1e67bfb248366d7395efdd2d5e70a97bdb2e68af | |
| ToppCell | droplet-Lung-1m-Endothelial-arterial_endothelial|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.39e-05 | 186 | 163 | 6 | ffbc78058be8f0dc2e0335cc4c3195a636d17721 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.39e-05 | 186 | 163 | 6 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 | |
| ToppCell | droplet-Lung-1m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.39e-05 | 186 | 163 | 6 | ed924852cd7132c8f6703522037dc22bd2c83193 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-OPC|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.58e-05 | 187 | 163 | 6 | daff7ccd3f1924cf2b34d3aca3eccde245aaf371 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.58e-05 | 187 | 163 | 6 | 3ae3b8de1a195d4d5057cf3c64fcdb5f48681ce5 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.58e-05 | 187 | 163 | 6 | c31130fc2f9f882944b2ba366a034a03f051c4b9 | |
| ToppCell | COVID-19-kidney|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.58e-05 | 187 | 163 | 6 | d23aae9419d460b78b1d4092d7acd9108a47cfbe | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.58e-05 | 187 | 163 | 6 | 5b7a1edee602e55d3400dc17dbb6b8aaa26defc0 | |
| ToppCell | COVID-19-kidney-Stressed_PCT|kidney / Disease (COVID-19 only), tissue and cell type | 6.58e-05 | 187 | 163 | 6 | acd305475f3609800af0d7bc68d83ef41228080b | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-neuro-epithelial-EECs|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.77e-05 | 188 | 163 | 6 | ed074572e61d97c139fb1636a78c9b71e2c44ce0 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.77e-05 | 188 | 163 | 6 | af740fa78542438fdff627ea1f74f4eee43316be | |
| ToppCell | COVID-19-Epithelial-Ionocytes|COVID-19 / Condition, Lineage and Cell class | 6.77e-05 | 188 | 163 | 6 | a581cb9528d0febbf3addbb4f6bc140f91a584e6 | |
| ToppCell | PND28-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.98e-05 | 189 | 163 | 6 | fa1ff8b7fa53f3148d9117d6e598097f03af5eb2 | |
| ToppCell | PBMC-Mild-cDC_12|Mild / Compartment, Disease Groups and Clusters | 6.98e-05 | 189 | 163 | 6 | 946c95d2ecc36b241f58e8c4ad6455fe47c762fa | |
| ToppCell | PND28-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.98e-05 | 189 | 163 | 6 | 565063f9e3dd79164321f8a394bd12c176baf202 | |
| ToppCell | PND28-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.98e-05 | 189 | 163 | 6 | 497be236848ebf5ad75d1f0c71e6261f5d3521da | |
| ToppCell | E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-Sox9_Epi|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.18e-05 | 190 | 163 | 6 | 422f58447e2b308f6f9dad822c4600c78e571c5d | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-intermediate_neuroendocrine|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 7.18e-05 | 190 | 163 | 6 | 5f1863bce9400b7c932f0e4d0e012ec4e8d7e555 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.18e-05 | 190 | 163 | 6 | 11d3c31167ea71809b4cc3757a0c6ea54a448602 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.18e-05 | 190 | 163 | 6 | 3f0c7d130f66faea778fe567604edf1b4cdf85b3 | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.39e-05 | 191 | 163 | 6 | acd844b477a069b2dcf07b2998e1b5c87dc0eb94 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.39e-05 | 191 | 163 | 6 | 3c464645d0e7e423f791bd63bf5bcf11f6b590d3 | |
| ToppCell | (01)_Dendritic_cell|World / immune cells in Peripheral Blood (logTPM normalization) | 7.39e-05 | 191 | 163 | 6 | 1f4c8078e1a6cd14937c714330af608caced2acf | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.39e-05 | 191 | 163 | 6 | 1c1d13144259b998d4a0e85142f7afef2ef1e63f | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Lymphocytic-immature_NKT_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.39e-05 | 191 | 163 | 6 | c8b99bd3a30c81ee4deba9cbf0196920ab3ab550 | |
| ToppCell | COPD-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 7.39e-05 | 191 | 163 | 6 | ef16ad1c1cd2c0c0377957398c98775b62a81754 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.39e-05 | 191 | 163 | 6 | f76f3f5c7902a3659d8cbe470f96ce57c8a6744d | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.39e-05 | 191 | 163 | 6 | 9032aa974aa1b7b1095b8d1b58dcb087358a5001 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-epithelial_progenitor_cell-Stem_cells|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.39e-05 | 191 | 163 | 6 | a8d77095ba20b47fc70ba04f80759fbce873253d | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.39e-05 | 191 | 163 | 6 | b133ee1c0e58d00ddd2e4e05b01fd04947524c18 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.39e-05 | 191 | 163 | 6 | 5717809a1476c20f65bce722c5a57cff92ee0d7a | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.61e-05 | 192 | 163 | 6 | 25492568f9cbe097b7bb1db50d8b817c80ea87d7 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-neurons_B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.61e-05 | 192 | 163 | 6 | 2f1c4ef693515ccc7231bd8c6641fad51d445d20 | |
| ToppCell | Ciliated-cil-3|World / Class top | 7.61e-05 | 192 | 163 | 6 | 4989ebb8812b8af1870599acd932849122c05a29 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.61e-05 | 192 | 163 | 6 | de9c1536d5aee86f9c62acbc54ca8fa581c00f17 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.61e-05 | 192 | 163 | 6 | c09dcc73ff9c3855a0f3d7bfa0d5c99c09a117f2 | |
| ToppCell | facs-Bladder-nan-3m-Epithelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.06e-05 | 194 | 163 | 6 | e74cd8cf3763f6adbfd1c269a886a806049714cf | |
| ToppCell | facs-Brain_Myeloid-Cortex-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.06e-05 | 194 | 163 | 6 | 2224c7c943cfd5c1a329dfcf19d6e5ef8c49d85d | |
| ToppCell | facs-Brain_Myeloid-Cortex-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.06e-05 | 194 | 163 | 6 | 50c5fc349533281a426bc7227a8ea9eca8d11985 | |
| ToppCell | facs-Brain_Myeloid-Cortex-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.06e-05 | 194 | 163 | 6 | 1662b110f84584e75150df0ac970e7df82f26e7e | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.06e-05 | 194 | 163 | 6 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | facs-Brain_Myeloid-Cortex-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.06e-05 | 194 | 163 | 6 | b31d6361fa939a92a4a3dc63c209ecd3eb514e6a | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.29e-05 | 195 | 163 | 6 | 3a0cad69cfc150a27a0666f612f5294c817197d7 | |
| ToppCell | Monocytes-NUPR1+_Monocytes|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 8.29e-05 | 195 | 163 | 6 | 5e12201ce7ba912e7faa123ca200e609252ba288 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.29e-05 | 195 | 163 | 6 | 2b8ee7990267bb52b7e6ae03f509ffebf8908122 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.29e-05 | 195 | 163 | 6 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.52e-05 | 196 | 163 | 6 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 8.52e-05 | 196 | 163 | 6 | 9591a6a3477ed6a1e2e016f7542e38603d8b16cb | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Macrophage-macrophage,_alveolar|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.52e-05 | 196 | 163 | 6 | 7ce416e1809bfbb39553c28c20125790100a938d | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.52e-05 | 196 | 163 | 6 | eea66711a16134f86e6c533a5a837ff2e0d7ca7f | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Macrophage|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.52e-05 | 196 | 163 | 6 | 292da8a0c052917a2f68afee9068b5b8e1544b13 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-6_mon-Neuronal-CPNs|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 8.52e-05 | 196 | 163 | 6 | c9e7ac34993c873de4f198cdae77dcf099731532 | |
| ToppCell | (3)_MNP-(3)_Macrophage_Dividing|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4) | 8.76e-05 | 197 | 163 | 6 | 048bc4f8fd5d4f394e2384700640f72042336597 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.76e-05 | 197 | 163 | 6 | 7e93a97b5ac5ae2f77a4b3141082a1463fed00dd | |
| ToppCell | URO-Myeloid-cDC2|URO / Disease, Lineage and Cell Type | 8.76e-05 | 197 | 163 | 6 | 7fee14356d7fba68a0515c8b9284568d14124b0a | |
| Drug | N,N-dimethylaniline-N-oxide | 6.92e-07 | 11 | 157 | 4 | CID000000950 | |
| Drug | Ccris 2188 | 3.18e-06 | 5 | 157 | 3 | CID000146896 | |
| Drug | NSC7524 | 5.01e-06 | 182 | 157 | 9 | CID000005657 | |
| Drug | N,N-dimethylaniline | 1.01e-05 | 42 | 157 | 5 | CID000000949 | |
| Drug | benzydamine N-oxide | 1.10e-05 | 7 | 157 | 3 | CID000065465 | |
| Drug | carvedilol | 1.64e-05 | 161 | 157 | 8 | CID000002585 | |
| Disease | myopathy (implicated_via_orthology) | 2.03e-07 | 48 | 156 | 6 | DOID:423 (implicated_via_orthology) | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 9.81e-07 | 15 | 156 | 4 | DOID:0050646 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | RAD51 FLNB MRPS28 NRCAM MECOM HEPACAM2 OLA1 STAT5A CLASRP EEF1B2 ARID1B BEND7 KDR BOD1L1 TIMELESS DLEC1 KLHDC7A TP53BP2 | 1.62e-05 | 1074 | 156 | 18 | C0006142 |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 1.69e-05 | 10 | 156 | 3 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 1.69e-05 | 10 | 156 | 3 | DOID:0111596 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 1.69e-05 | 10 | 156 | 3 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 1.69e-05 | 10 | 156 | 3 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 1.69e-05 | 10 | 156 | 3 | DOID:0111605 (implicated_via_orthology) | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 1.69e-05 | 10 | 156 | 3 | DOID:0111269 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 1.69e-05 | 10 | 156 | 3 | DOID:0110454 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 1.69e-05 | 10 | 156 | 3 | DOID:0080326 (implicated_via_orthology) | |
| Disease | S-methylcysteine measurement | 2.78e-05 | 2 | 156 | 2 | EFO_0800054 | |
| Disease | SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME | 2.78e-05 | 2 | 156 | 2 | C1848934 | |
| Disease | myotonia congenita (implicated_via_orthology) | 3.08e-05 | 12 | 156 | 3 | DOID:2106 (implicated_via_orthology) | |
| Disease | distal myopathy (implicated_via_orthology) | 3.08e-05 | 12 | 156 | 3 | DOID:11720 (implicated_via_orthology) | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 3.99e-05 | 13 | 156 | 3 | DOID:397 (implicated_via_orthology) | |
| Disease | high grade glioma (is_marker_for) | 7.19e-05 | 42 | 156 | 4 | DOID:3070 (is_marker_for) | |
| Disease | myofibrillar myopathy 5 (implicated_via_orthology) | 8.30e-05 | 3 | 156 | 2 | DOID:0080096 (implicated_via_orthology) | |
| Disease | distal muscular dystrophy 4 (implicated_via_orthology) | 8.30e-05 | 3 | 156 | 2 | DOID:0111190 (implicated_via_orthology) | |
| Disease | sitting height ratio | 1.55e-04 | 51 | 156 | 4 | EFO_0007118 | |
| Disease | otitis media (implicated_via_orthology) | 2.07e-04 | 22 | 156 | 3 | DOID:10754 (implicated_via_orthology) | |
| Disease | complement factor H-related protein 1 measurement | 2.23e-04 | 56 | 156 | 4 | EFO_0600054 | |
| Disease | epilepsy (implicated_via_orthology) | 2.38e-04 | 163 | 156 | 6 | DOID:1826 (implicated_via_orthology) | |
| Disease | Hypophosphatemic rickets | 2.75e-04 | 5 | 156 | 2 | cv:C1704375 | |
| Disease | Rickets | 2.75e-04 | 5 | 156 | 2 | cv:C0035579 | |
| Disease | Hereditary hypophosphatemic rickets | 2.75e-04 | 5 | 156 | 2 | cv:CN296404 | |
| Disease | Digitotalar Dysmorphism | 4.11e-04 | 6 | 156 | 2 | C1852085 | |
| Disease | Carcinoma, Lobular | 4.11e-04 | 6 | 156 | 2 | C0206692 | |
| Disease | ARTHROGRYPOSIS, DISTAL, TYPE 1 | 4.11e-04 | 6 | 156 | 2 | C0220662 | |
| Disease | somatostatin-28 measurement | 4.11e-04 | 6 | 156 | 2 | EFO_0020745 | |
| Disease | endothelial cell-selective adhesion molecule measurement | 4.11e-04 | 6 | 156 | 2 | EFO_0008120 | |
| Disease | riboflavin kinase measurement | 4.11e-04 | 6 | 156 | 2 | EFO_0802016 | |
| Disease | intellectual disability (is_implicated_in) | 5.30e-04 | 30 | 156 | 3 | DOID:1059 (is_implicated_in) | |
| Disease | cardiomyopathy (implicated_via_orthology) | 5.55e-04 | 71 | 156 | 4 | DOID:0050700 (implicated_via_orthology) | |
| Disease | Breast Carcinoma | RAD51 MRPS28 NRCAM MECOM STAT5A EEF1B2 ARID1B KDR KLHDC7A TP53BP2 | 6.10e-04 | 538 | 156 | 10 | C0678222 |
| Disease | serum urea measurement | 6.17e-04 | 195 | 156 | 6 | EFO_0009795 | |
| Disease | microcephaly (is_implicated_in) | 7.62e-04 | 8 | 156 | 2 | DOID:10907 (is_implicated_in) | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 8.70e-04 | 80 | 156 | 4 | DOID:12930 (implicated_via_orthology) | |
| Disease | dickkopf-like protein 1 measurement | 9.76e-04 | 9 | 156 | 2 | EFO_0020324 | |
| Disease | post-traumatic stress disorder (biomarker_via_orthology) | 9.76e-04 | 9 | 156 | 2 | DOID:2055 (biomarker_via_orthology) | |
| Disease | Distal arthrogryposis | 9.76e-04 | 9 | 156 | 2 | cv:C0265213 | |
| Disease | SPINOCEREBELLAR ATAXIA 17 | 9.76e-04 | 9 | 156 | 2 | C1846707 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 1.06e-03 | 145 | 156 | 5 | DOID:1289 (implicated_via_orthology) | |
| Disease | neutrophil count | PRUNE2 FLNB MYO1E KMT5A IQSEC2 SYT6 ASH1L NSD1 MECOM CIT CBS EFHC1 BEND7 TBC1D14 IQSEC1 SYN2 TNS3 | 1.07e-03 | 1382 | 156 | 17 | EFO_0004833 |
| Disease | neuroblastoma (is_implicated_in) | 1.22e-03 | 10 | 156 | 2 | DOID:769 (is_implicated_in) | |
| Disease | spondylosis | 1.24e-03 | 40 | 156 | 3 | MONDO_0002253 | |
| Disease | heart rate | 1.29e-03 | 225 | 156 | 6 | EFO_0004326 | |
| Disease | Neurodevelopmental Disorders | 1.52e-03 | 93 | 156 | 4 | C1535926 | |
| Disease | glioblastoma (is_marker_for) | 1.64e-03 | 44 | 156 | 3 | DOID:3068 (is_marker_for) | |
| Disease | C-C motif chemokine 28 measurement | 1.77e-03 | 12 | 156 | 2 | EFO_0020199 | |
| Disease | cleft palate (is_implicated_in) | 1.77e-03 | 12 | 156 | 2 | DOID:674 (is_implicated_in) | |
| Disease | Mammary Carcinoma, Human | 1.98e-03 | 525 | 156 | 9 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 1.98e-03 | 525 | 156 | 9 | C1257931 | |
| Disease | Mammary Neoplasms | 2.03e-03 | 527 | 156 | 9 | C1458155 | |
| Disease | Erythrocyte Mean Corpuscular Hemoglobin Test | 2.08e-03 | 13 | 156 | 2 | C0369183 | |
| Disease | Finding of Mean Corpuscular Hemoglobin | 2.08e-03 | 13 | 156 | 2 | C1261502 | |
| Disease | ocular hypertension, response to triamcinolone acetonide | 2.23e-03 | 49 | 156 | 3 | EFO_0006954, EFO_1001069 | |
| Disease | lentiform nucleus measurement | 2.42e-03 | 14 | 156 | 2 | EFO_0004913 | |
| Disease | susceptibility to bacterial meningitis measurement | 2.65e-03 | 52 | 156 | 3 | EFO_0008411 | |
| Disease | corpus callosum posterior volume measurement | 2.65e-03 | 52 | 156 | 3 | EFO_0010298 | |
| Disease | Autosomal recessive primary microcephaly | 2.79e-03 | 15 | 156 | 2 | cv:C3711387 | |
| Disease | Sinus Node Dysfunction (disorder) | 2.79e-03 | 15 | 156 | 2 | C0428908 | |
| Disease | forehead morphology measurement | 2.79e-03 | 15 | 156 | 2 | EFO_0007844 | |
| Disease | inherited metabolic disorder (is_implicated_in) | 2.79e-03 | 15 | 156 | 2 | DOID:655 (is_implicated_in) | |
| Disease | body weight | DOCK1 TBX22 TRAF3 RPGRIP1L NRCAM MECOM GRID2 SHTN1 ADCY6 PAX8 PTPRR CPVL AKAP7 PDZD2 EPHB1 | 2.89e-03 | 1261 | 156 | 15 | EFO_0004338 |
| Disease | Antihypertensive use measurement | 2.94e-03 | 265 | 156 | 6 | EFO_0009927 | |
| Disease | response to acetylsalicylate | 3.17e-03 | 16 | 156 | 2 | GO_1903492 | |
| Disease | testosterone measurement | CACNA1D MYH2 CACNA2D1 FMO3 CENPE NPEPPS IQSEC2 MECOM ADCY6 ARID1B CLYBL TGDS RIMBP2 CTPS1 TNS3 | 3.21e-03 | 1275 | 156 | 15 | EFO_0004908 |
| Disease | Prescription Drug Abuse | 3.30e-03 | 115 | 156 | 4 | C4316881 | |
| Disease | Substance-Related Disorders | 3.30e-03 | 115 | 156 | 4 | C0236969 | |
| Disease | Organic Mental Disorders, Substance-Induced | 3.30e-03 | 115 | 156 | 4 | C0029231 | |
| Disease | Drug habituation | 3.30e-03 | 115 | 156 | 4 | C0013170 | |
| Disease | Drug abuse | 3.30e-03 | 115 | 156 | 4 | C0013146 | |
| Disease | Drug Use Disorders | 3.30e-03 | 115 | 156 | 4 | C0013222 | |
| Disease | Drug Dependence | 3.30e-03 | 115 | 156 | 4 | C1510472 | |
| Disease | Substance Dependence | 3.30e-03 | 115 | 156 | 4 | C0038580 | |
| Disease | Substance Use Disorders | 3.30e-03 | 115 | 156 | 4 | C0038586 | |
| Disease | Substance abuse problem | 3.40e-03 | 116 | 156 | 4 | C0740858 | |
| Disease | refractive error, age at onset, Myopia | 3.70e-03 | 193 | 156 | 5 | EFO_0004847, HP_0000545, MONDO_0004892 | |
| Disease | Bipolar Disorder | 3.99e-03 | 477 | 156 | 8 | C0005586 | |
| Disease | abdominal fat cell number | 4.12e-03 | 198 | 156 | 5 | EFO_0021534 | |
| Disease | Chronic myeloproliferative disorder | 4.48e-03 | 19 | 156 | 2 | C1292778 | |
| Disease | inferior parietal cortex volume measurement | 4.48e-03 | 19 | 156 | 2 | EFO_0010307 | |
| Disease | diet measurement, body mass index | 4.96e-03 | 20 | 156 | 2 | EFO_0004340, EFO_0008111 | |
| Disease | coagulation factor measurement | 4.96e-03 | 20 | 156 | 2 | EFO_0004634 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RPEGYNLKDEEGKLK | 126 | Q9Y2T4 | |
| TYCKGRPKGVKEQDV | 2766 | Q9NR48 | |
| VKGKPLISRNYKGDV | 11 | Q9Y6Q5 | |
| KEVVEGKKEPGYIRA | 591 | O76031 | |
| KVLAKYGVNPERIGI | 171 | P22760 | |
| KQYQDLGAKIPKGAI | 331 | Q9Y4W6 | |
| LRKNGVKKIDPDLYE | 231 | Q9P0M2 | |
| YQLECRGVVKVKGKG | 1141 | O43306 | |
| VKLVPDGKYGAQNDK | 496 | P39086 | |
| KHGYIPGKNRDLKVV | 391 | Q9ULV4 | |
| KIKYSGGPQIVKKER | 71 | Q14738 | |
| LGGVKYDIDLPNKKV | 26 | O00244 | |
| KNKVGREGIIPANYV | 51 | P41240 | |
| KITKVYELGNEPERK | 1126 | Q8NFD5 | |
| VHLVPDRKKDQYKVG | 576 | P08603 | |
| KICGPRYGETKEKDI | 681 | Q14004 | |
| YDPKGLTIFAGRKKI | 546 | Q96MT7 | |
| LKAKDQGKPEVGEYA | 611 | O14578 | |
| QGKPEVGEYAKLEKI | 616 | O14578 | |
| QIYREKPGNKVADKG | 3351 | Q8IZT6 | |
| VKVPGEYRRKENGVN | 106 | Q13625 | |
| RAVLYVPGNDEKKIK | 46 | Q8N0X4 | |
| GKIIIRNPIKIGYGK | 436 | Q96T37 | |
| RGKQKEKGYRHKVPQ | 401 | Q96L73 | |
| PKVVEKIGDYKRQNP | 86 | Q06710 | |
| AVAYAPKKELINIKG | 51 | Q06609 | |
| GKYIPLEIDKKVTRD | 61 | A0A1B0GVH7 | |
| AVRGGDKKLKPEYDI | 171 | Q9NTK5 | |
| GKCEIKVAQPKEVYR | 301 | O14979 | |
| TKRKIEVGEKFGPYV | 96 | Q03112 | |
| IKAIPRFNQKGEVYK | 426 | P11182 | |
| GEVYKGRLKLPGKRE | 631 | P54762 | |
| YKEPGVFNGKRVLVV | 176 | P31513 | |
| EVKCQGKPLAGIYRK | 121 | Q9NQR1 | |
| VGGYERPFAQIKVTK | 491 | O60942 | |
| VNDKKRYERVGGGPK | 86 | Q68CZ1 | |
| RRNKGGKYPVKEKED | 1191 | Q92823 | |
| DYVEDGKGIRRVKPK | 421 | Q9BZ67 | |
| RESYGVIEQKKLIPG | 861 | Q15034 | |
| GKGVIRGNKEYKEEK | 86 | Q96BZ8 | |
| NKKPEKGVQYLIERG | 536 | Q6DN90 | |
| KKPEKGIQYLIERGF | 766 | Q5JU85 | |
| TPYIEAGKIQKGREL | 46 | Q9H3G5 | |
| KYKIAIVPDGKYGAR | 461 | P48058 | |
| LGKPKKYQGFSIDVL | 461 | O43424 | |
| KLNPKKARAYGRGIE | 251 | O75369 | |
| VSEGGKPKVQVEYKG | 96 | P54652 | |
| EKPQYKEDGKLQLVG | 2711 | Q9Y6V0 | |
| KPEVVTAYRGKKRQE | 136 | Q9UKX2 | |
| PLVIKRVYKGGAAEQ | 2776 | O15018 | |
| RVKVYGPGVEKTGLK | 766 | Q14315 | |
| YKIPEGFQGKRVLVI | 176 | P31512 | |
| KKYGIPFDKVTQEAG | 251 | O75164 | |
| TKGPKSEREGKVYGQ | 846 | Q0VF49 | |
| VINEGGKPKVLVSYK | 96 | P34931 | |
| KIEQDYTLVPRKGVK | 441 | Q8N8V2 | |
| LGDVKNIKVIYGPAA | 441 | P22413 | |
| YKNPEAFKGKRVLVI | 176 | O60774 | |
| KEESLGPKRQKVGFL | 276 | Q15024 | |
| KRFEEGVGKPAKQLQ | 691 | Q8IYI6 | |
| GQYPVKSEGKELKIV | 271 | O94916 | |
| EKGKLGQYIRLVEPG | 31 | O14745 | |
| PEKRGIYGKVEVLVI | 506 | Q15256 | |
| HERVPKKEVKVNKYG | 226 | Q9NX40 | |
| KHAIIVEPEKRGKYV | 101 | P09467 | |
| KEKKYQEDFNPLVRG | 336 | Q9H974 | |
| VLGKDGKPVSEYIIK | 801 | Q8NFC6 | |
| IKSKIDIKGGYQKPQ | 226 | Q9H1X3 | |
| TKVLKNYVDGAEKPG | 716 | Q14185 | |
| YIGGDDEPQEKKRKA | 616 | P49917 | |
| VLEKPLEKKSGRNYG | 2496 | Q9UFH2 | |
| RIPISKAGKEIKEYV | 26 | O14610 | |
| YIQGKLLKPAVVGIK | 801 | P54289 | |
| EKVPKGGDYLQIKNA | 406 | A2CJ06 | |
| DYKNPEGFTGKRVII | 176 | P49326 | |
| PDGKVEKVYKNGCRV | 1156 | Q9HC77 | |
| EEAKRVYLKPKGEQG | 901 | Q86WZ0 | |
| GKVQPSDQVGKVIYK | 471 | P35520 | |
| LKKIGYPKADNLNGE | 11 | Q68CZ6 | |
| VEEKVRKQTKGLYPA | 286 | P40939 | |
| IIGGKYLGRTKVVKP | 461 | Q5JVL4 | |
| VAKQCYERGEKPKVT | 216 | Q14204 | |
| NKAVAPLIKGIFKGY | 66 | Q2VIQ3 | |
| QKAEGVEPRLKGKVY | 276 | Q5VTJ3 | |
| EDYIKVQKARGLEPK | 16 | Q9NPI7 | |
| GRIYQRVGKEGEKLK | 71 | Q8N7W2 | |
| GAVVPLVGKLKKFYE | 81 | Q9NUQ9 | |
| IKQKLEGRPETEYRK | 381 | A8MVW5 | |
| GKEPKEGERKIYLAI | 976 | Q7L014 | |
| GVKKALGKYGPADVE | 71 | P24534 | |
| EKKTKPYIQVDIGGG | 121 | P11021 | |
| PGENYIGINVKKAFK | 766 | Q9Y238 | |
| TPVGVVVYKNKKQVG | 226 | Q9HCS5 | |
| GKPKQKVIIADCGEY | 286 | Q9UNP9 | |
| EINERKEKTKPVPGY | 191 | Q9BZW2 | |
| TQKEAGIYPRKGKQT | 526 | Q4U2R8 | |
| QPGDYIIREGTIGKK | 566 | Q9UL51 | |
| VRVYTPVGKAEQGKF | 266 | P55786 | |
| KRKEQGLVGKYPAKN | 1621 | Q01668 | |
| VLQDKVALGAKPYKE | 2441 | Q02224 | |
| DDVKGIQALYGPRKV | 261 | O60882 | |
| RPEVDGEKYQKGTRV | 126 | Q9Y2Q9 | |
| DPYVKVHLLQGGKKV | 276 | O00445 | |
| RIKPELYKQKSVDGE | 206 | Q5T7P8 | |
| GPKIDIQIKDAIGRY | 541 | P26639 | |
| RGKKVLGDYDIKVEQ | 131 | Q92777 | |
| PFKEGQIIKVYGDKD | 876 | O15034 | |
| IKVKPKRVGIFLDYE | 451 | Q9HCM9 | |
| GYEKGQPDEELKPKK | 471 | P54577 | |
| NGLVDPKTRGKVYEK | 901 | Q8WUY3 | |
| LDLGYKPGVEAIRKN | 526 | P28331 | |
| IYDVVRKGKNEVKPV | 81 | Q8NE09 | |
| KLNPKKYEGGRELSD | 461 | P30101 | |
| FGVKKKPIYINVIRD | 151 | Q7LGA3 | |
| ERKGDYLGKTVQVVP | 101 | P17812 | |
| IGERGNKKGKVPVTY | 376 | Q9NR46 | |
| RKKYIDGEKQAEPVV | 566 | A0MZ66 | |
| KKYARVEKIPGGIIE | 196 | P49368 | |
| NPEVVEGYRGKKRQE | 136 | P11055 | |
| GYPTIKILKKGQAVD | 136 | P13667 | |
| IPANYVKILGKRKGR | 326 | Q92968 | |
| VRQIYDKFPEKKGGL | 271 | Q15562 | |
| IQKYLGDGPKLVREL | 256 | P62191 | |
| QGPVDGSLYAKVRKK | 346 | Q68CZ2 | |
| VSAVIKPYPKGDERK | 211 | A4QPH2 | |
| PAGKQKLQYEGIFIK | 751 | Q15459 | |
| KIGRPGYKVTKQRDS | 111 | Q15428 | |
| IQTVGPGKKYKVKFD | 221 | Q15047 | |
| VLAKAVDGYVKPQIK | 686 | P42229 | |
| YPEAKKALEEKGRQI | 591 | Q16281 | |
| LYGGLQRPSEDEKKK | 141 | Q8N2M8 | |
| GVKYAEKQERKFEPG | 141 | P51911 | |
| SKRIQKEYEDKAGRP | 276 | Q9P2M4 | |
| LKKGKPGEIYNIGTN | 246 | O95455 | |
| APGIQKKKRYQIEDD | 1191 | Q9UNS1 | |
| KGEVPDGYNVSRLKK | 76 | A0A0J9YXY3 | |
| VFVPEQGGYKEKFVK | 31 | Q13114 | |
| YAPGTEGNVKRKIRK | 21 | O95625 | |
| KGEVPDGYNVSRLKK | 76 | P0DPF7 | |
| RVKVKGLDPGKQYHV | 126 | Q9Y458 | |
| GKFKLPAGDLQERKV | 76 | O60499 | |
| AVERKIEPFYKGGKA | 16 | Q12788 | |
| RRIEIEENKKQGKYP | 616 | Q8N5U6 | |
| VDVRQIYDKFPEKKG | 266 | Q99594 | |
| LPARQEGVKKKAAEY | 311 | Q9NRS6 | |
| KPEVVAAYRGKKRQE | 136 | Q9UKX3 | |
| KEKARAVLAKVGYPE | 466 | P78562 | |
| RKYPKLKEVDDVLGG | 41 | Q9Y2Y1 | |
| AGVVQSPRYKIIEKK | 21 | A0A5A6 | |
| KGDVPEGYKVSRKEK | 76 | A0A0K0K1C4 | |
| GIYQKILAGKIDFPR | 251 | P51817 | |
| DIRQIYDKFPEKKGG | 266 | Q15561 | |
| YIRGGIVSQVKVPKK | 286 | P22314 | |
| KGPKERGSKKDYIQE | 331 | Q9UJA5 | |
| VKDPDGKVVLSRQYG | 81 | Q7Z7H5 | |
| LKRPVVYVKGADAIK | 176 | Q9ULT6 | |
| RQGKDYVGAIPVDLK | 946 | P35968 | |
| NGKAAYTGPKERVIK | 476 | Q9WJR5 | |
| FQKERGKKPKETYGG | 266 | Q96IQ7 | |
| VAKKGKDVALRYDPI | 31 | A0A0A6YYK4 | |
| QSVVRDLKGYPDGVK | 411 | Q9H808 | |
| DLKGYPDGVKSIVVK | 416 | Q9H808 | |
| VAEGKYKEKGIPALI | 261 | P35573 | |
| LYLIGREKVKQGPDK | 791 | Q12965 | |
| PKCVYVIGREKVKKG | 786 | O00160 | |
| KILDPAYQVDKGGRV | 256 | Q00872 | |
| KLDPAYQVDRGNKIK | 261 | Q14324 | |
| KRIEAIVKNYPEGHK | 61 | P19404 |